meglumine has been researched along with gadolinium in 491 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (2.04) | 18.7374 |
1990's | 274 (55.80) | 18.2507 |
2000's | 80 (16.29) | 29.6817 |
2010's | 96 (19.55) | 24.3611 |
2020's | 31 (6.31) | 2.80 |
Authors | Studies |
---|---|
Aicher, KP; Engelstad, BL; Kucharczyk, J; Moseley, ME; Tzika, AA; White, DL | 1 |
Fairclough, DL; Fletcher, BD; Gronemeyer, SA; Hanna, SL | 1 |
Børseth, A; Myhr, G; Rinck, PA | 1 |
Greenberg, HM; Kroeker, MA; Lawrence, PH; Madden, TP; Semelka, RC; Shoenut, JP | 1 |
Mirowitz, SA | 1 |
Charpentier, A; de Baere, T; di Paola, M; Shapeero, LG; Terrier, P; Vanel, D | 1 |
Chaljub, G; Crow, WN; Guinto, FC; Kumar, R; Martinez, L; Van Fleet, R | 1 |
Bazan, C; Gee, GT; Jinkins, JR | 1 |
Bhatti, SU; Crumrine, RC; Finelli, DA; Hopkins, AL; Lust, WD; Selman, WR | 1 |
Hiramatsu, K; Imai, Y; Izutsu, M; Tachibana, M; Tanimoto, A; Tazaki, H; Yuasa, Y | 1 |
Bernreuter, WK; Kenney, PJ; Listinsky, JJ; Morgan, DE; Rominger, MB | 1 |
Fritz, RC; Stoller, DW | 1 |
Dangman, BC; Hoffer, FA; O'Rourke, EJ; Rand, FF | 1 |
Hirai, Y; Hiramatsu, Y; Hirano, Y; Kubo, K; Okada, S; Sawano, S; Yamada, K; Yamashita, T | 1 |
Finck, S; Göranson, H; Honda, G; Hricak, H | 1 |
Algra, PR; Barkhof, F; Heijboer, RJ | 1 |
Goldstein, HA; Kashanian, F; Wiggins, JR | 1 |
Bidgood, WD; Guy, J; Mancuso, A; Mao, J; Quisling, RG | 1 |
Beck, B; Ellis, EA; Fitzsimmons, J; Guy, J; Mancuso, A | 1 |
Balzer, J; Lissner, J; Pegios, W; Pirovano, G; Vogl, TJ; Waitzinger, J | 1 |
Clauss, W; Haustein, J; Junge, W; Krestin, G; Louton, T; Niendorf, HP; Schuhmann-Giampieri, G | 1 |
Brasch, RC; Higgins, CB; Mühler, A; Saeed, M | 1 |
Berthezène, Y; Brasch, RC; Clément, O; Mühler, A; Rosenau, W; Vexler, V | 1 |
Runge, VM | 2 |
Austin, HA; Choyke, PL; Frank, JA; Girton, ME; Weiss, G | 1 |
Cavagna, F; Daprà, M; de Haën, C; Felder, E; Maggioni, F | 1 |
Cann, CE; Hamm, B; Hricak, H; Nauert, T; Secaf, E; Semelka, RC; Stern, JL; Wolf, KJ | 1 |
Beltran, J; Chandnani, V; Kursunoglu-Brahme, S; McGhee, RA | 1 |
Hricak, H; Stern, JL; Stevens, SK | 1 |
Carroll, PR; Finegold, R; Hricak, H; Semelka, RC; Stevens, SK; Tomei, E | 1 |
Bernardino, ME; Fernandez, MP; Neylan, JF; Olson, RA | 1 |
Crain, MR; Ehrhardt, JC; Engelken, JD; Fisher, DJ; Greene, GM; Ryals, TJ; Sato, Y; Yuh, WT | 1 |
Camponovo, E; Citrin, CM; Sherman, JL | 1 |
Lim, V; Sobel, DF; Zyroff, J | 1 |
Breit, R; Friedman, H; Kim, KS; Kimura, F; Russell, EJ | 1 |
Sherman, JL; Stern, BJ | 1 |
Golman, K; Holtz, E; Klaveness, J; Leander, P; Leunbach, I; Olsson, M | 1 |
Clark, OH; DeMarco, R; Higgins, CB; Seelos, KC | 1 |
Gries, H; Press, WR; Weinmann, HJ | 1 |
Engel, A; Gylys-Morin, V; Haghighi, P; Hajek, PC; Kramer, F; Neumann, CH; Resnick, D; Sartoris, DJ | 1 |
Buoni, C; Felder, E; Musu, C; Passariello, R; Patrizio, G; Pavone, P; Tettamanti, E; Tirone, P | 1 |
Cardone, G; Felder, E; Musu, C; Passariello, R; Patrizio, G; Pavone, P; Pietroletti, R; Tettamanti, E | 1 |
Blumenfield, DM; Blumetti, RF; Goldstein, HA; Holyoak, WL; Hugo, FP; Kashanian, FK | 1 |
Kieffer, SA | 1 |
Brasch, RC; Dupon, JW; Kopplin, J; Moseley, ME; White, DL; Wikström, MG; Winkelhake, JL | 1 |
Bielke, G; Grigat, M; Higer, HP; Jungke, M; Just, M; Kunze, S; Meindl, S; Pedrosa, P; Voth, D | 1 |
Bravo, S; Krol, G; Sze, G | 1 |
Braunschweiger, PG; Furmanski, P; Schiffer, L | 1 |
Felder, E; Lorusso, V; Tirone, P; Vittadini, G | 1 |
Atlas, SW; Galetta, S; Gonzalez-Scarano, F; Grossman, RI; Silberberg, DH | 1 |
Braunschweiger, PG; Furmanski, P; Schiffer, LM | 1 |
Di Chiro, G; Dietz, MJ; Dwyer, AJ; Frank, JA; Gansow, OA; Girton, ME; Wright, DC | 1 |
Felix, R; Laniado, M; Schörner, W; Speck, U; Weinmann, HJ | 1 |
Laniado, M; Mützel, W; Weinmann, HJ | 1 |
Arredondo, MA; Blumenson, LE; Edge, SB; Herman, S; Klippenstein, DL; Mazurchuk, RV; Stomper, PC; Winston, JS | 1 |
Aisen, AM; Dunnick, NR; Francis, IR; Gross, MD; Korobkin, M; Lombardi, TJ; Londy, F; Quint, LE; Shapiro, B; Thompson, NW | 1 |
Bluemke, DA; Petri, M; Zerhouni, EA | 1 |
Epstein, FJ; Fine, MJ; Freed, D; Kricheff, II | 1 |
Barentsz, JO; Boetes, C; Hendriks, JH; Holland, R; Mus, RD; Ruys, SH; Strijk, SP; Wobbes, T | 1 |
Chenevert, TL; Cho, KJ; Marx, MV; Narasimham, DL; Prince, MR; Stanley, JC; Williams, DM | 1 |
Caslowitz, PL; Palmer, WE | 1 |
Genant, HK; Gooding, CA; Honda, G; Johnston, JO; Lang, P; Mathur, A; Peterfy, C; Roberts, T; Rosenau, W; Vahlensieck, M | 1 |
Briggs, RW; Burton, SS; Gauger, J; Mao, J; Ros, PR; Rosenberg, EB; Stoupis, C; Wilcox, C | 1 |
Kransdorf, MJ | 1 |
Bydder, GM; deSouza, NM; Gilderdale, DJ; Puni, R | 1 |
Gifford, LM; Gross, CA; Lasser, TA; Lauber-Huber, C; Nelson, KL | 1 |
Amiel, M; Chazel, S; Douek, PC; Falise, B; Revel, D; Villard, J | 1 |
Lopez, AJ; MacVicar, DA; Padhani, AR; Revell, PB | 1 |
Brossmann, J; Goodwin, DW; Resnick, DL; Salonen, DC; Trudell, DJ; Yu, JS | 1 |
Adamis, MK; Edelman, RR; Kent, KC; Kim, D; Li, W; Sax, EJ; Wielopolski, PA | 1 |
Bartlett, ST; Chow, CC; Daly, B; Krebs, TL; Wong, JJ | 1 |
Adam, G; Casser, R; Günther, RW; Peiss, J; Urhahn, R | 1 |
Bartl, R; Beck, R; Reiser, M; Schmidt, D; Stäbler, A | 1 |
Degryse, H; Ramon, F; van Bree, H; Van Ryssen, B | 1 |
Kuijpers, TJ; Oudkerk, M; Sijens, PE; Van Beek, EJ | 1 |
Marunaka, Y; Nakahari, T | 1 |
Jones, RV; Meltzer, CC; Smirniotopoulos, JG | 1 |
Haughton, VM; Hyde, JS; Ibrahim, MA | 1 |
Baert, AL; Demaerel, P; Lateur, L; van Ongeval, C; Wilms, G | 1 |
Ahmadi, J; Hinton, DR; Meyers, GS; Segall, HD; Sharma, OP | 1 |
Raaphorst, GP; Saunders, JK; Smith, IC; Sutherland, GR; Wilkins, DE | 1 |
Baratti, C; Campi, A; Comi, G; Filippi, M; Martinelli, V; Rovaris, M; Scotti, G | 1 |
Forsting, M; Heiland, S; Reith, W; Sartor, K; Vogler, H | 1 |
Brunberg, JA; Chandler, WF; Eldevik, OP; Hald, JK | 1 |
Becker, CR; Brix, G; Gückel, F; Lorenz, WJ; Rempp, KA; Wenz, F | 1 |
An, H; Hasegawa, T; Haughton, VM; Ho, KC; Nguyen, C | 1 |
Cha, SH; Chang, KH; Han, MC; Han, MH; Kim, HD; Ra, DG | 1 |
Chess, MA; Meyers, SP; Tarr, RW; Wildenhain, S | 1 |
Higano, S; Ikeda, H; Ishii, K; Matsumoto, K; Sakamoto, K; Takahashi, S | 1 |
Mikulis, D; Montanera, W; Terbrugge, K; Wallace, MC; Willinsky, R | 1 |
Colombo, N; Loli, P; Scialfa, G; Vignati, F | 1 |
Kenney, J; Krueck, WG; Maravilla, KR; Schmiedl, UP; Spence, AM; Starr, FL | 1 |
Mittl, RL; Yousem, DM | 1 |
Friedman, H; Schumacher, DJ; Tien, RD | 1 |
Carmody, RF; Goodwin, JA; Haery, C; Mafee, MF; Small, K | 1 |
Grand, MG; Ibanez, HE; Meredith, TA; Wippold, FJ | 1 |
Brunberg, JA; Eldevik, OP | 1 |
deSouza, NM; Gilderdale, DJ; Hawley, IC; Schwieso, JE; Soutter, WP | 1 |
Fischer, U; Funke, M; Grabbe, E; Keating, D; Kopka, L; Oestmann, J | 1 |
Chandnani, VP; Christensen, KP; Chung, EM; Gagliardi, JA; Hansen, MF; Kesling, KL; Null, RN; Radvany, MG | 1 |
Bishop, JE; George, S; Keller, MA; Kucharczyk, W; Plewes, DB | 1 |
Friedmand, DP; Hills, JR | 1 |
Arita, T; Choji, T; Fujita, T; Honjo, K; Ito, K; Matsumoto, T; Nakanishi, T | 1 |
Fujita, T; Ito, K; Matsui, M; Matsumoto, T; Nakanishi, T; Tanaka, N; Tsukamoto, K; Uchisako, H | 1 |
Edelman, RR; Li, W | 1 |
Baert, AL; Casselman, J; Defloor, E; Delanote, G; Demaerel, P; Dewulf, P; Wilms, G | 1 |
De Potter, P; Flanders, AE; Gonzales, CF; Rao, VM; Shields, CL; Shields, JA | 1 |
Prince, MR | 1 |
Maravilla, KR; Rand, S; Schmiedl, U | 1 |
Anzai, LL; Witte, RJ | 1 |
Bryan, RN; Mathews, VP; Monsein, LH; Pardo, CA | 1 |
Campos, Z; Gildengorin, V; Göranson, H; Hricak, H; Quivey, JM; Swift, PS | 1 |
Crim, JR; Seeger, LL | 1 |
Anderson, B; Brown, BP; Buller, RE; Hussey, DH; Mayr, NA; Tali, ET; Wen, BC; Yuh, WT | 1 |
Ito, M; Katabuchi, H; Miyazaki, K; Okamura, H; Takahashi, M; Tanaka, N; Torashima, M; Yamashita, Y | 1 |
Aruga, H; Kobayashi, T; Noguchi, Y; Okumura, T; Takashima, S | 1 |
Dabatin, JF; Francis, IR; Glazer, GM; Herfkens, RJ; Jeffrey, RB; Li, KC; Low, RN; McDonnell, CH; Van Dalsem, WJ; Whitney, WS | 1 |
Baron, RL; Confer, SR; Dodd, GD; Federle, MP; Ohtomo, K; Ohtomo, Y | 1 |
Brix, G; Engenhart, R; Frohmuller, S; Hess, T; Layer, G; Müller-Schimpfle, M; Schlag, P; Semmler, W; van Kaick, G; Zuna, I | 1 |
Fritz-Zieroth, B; Katamoto, H; Kotani, T; Nakata, E; Ohashi, F; Onishi, T | 1 |
Bakke, SJ; Hald, JK; Nakstad, PH; Skalpe, IO | 1 |
Labaisse, MA; Maldague, BE; Malghem, JJ; Noel, HM; Vande Berg, BE | 1 |
Mihara, F; Numaguchi, Y; Rigamonti, D; Rothman, MI; Sadato, N; Sato, S | 1 |
Peters, JL; Shaw, DD | 1 |
Akine, Y; Fukumori, Y; Ichikawa, H; Jono, K; Kanamori, R; Miyamoto, M; Tokita, N; Tokumitsu, H | 1 |
Finelli, DA; Kaufman, B | 1 |
Di Chiro, G; Dwyer, AJ; Fulham, MJ; Melisi, JW; Nishimiya, J | 1 |
Ide, H; Ishii, Y; Itoh, S; Kobayashi, H; Kubota, T; Maeda, M; Matsuda, T | 1 |
Hayashi, N; Ishii, Y; Itoh, S; Iwasaki, T; Kimura, H; Kubota, T; Maeda, M; Yamamoto, K | 1 |
Colletti, PM; Horvath, BC; Kwong, PK; Suthar, M; Terk, MR | 1 |
Cumming, MJ; Greenberg, HM; Kroeker, MA; Magro, CM; Semelka, RC; Shoenut, JP; Yaffe, CS | 1 |
Miyazaki, K; Okamura, H; Takahashi, M; Yamashita, Y | 1 |
Andoh, K; Itoh, Y; Kinno, Y; Odagiri, K; Tarao, K | 1 |
Akine, Y; Churei, H; Kanda, K; Kobayashi, T; Le Pechoux, C; Satoh, M; Tokita, N; Tokuuye, K | 1 |
Brown, JJ; Eilenberg, SS; Heiken, JP; Lee, JK; Mirowitz, SA | 1 |
Mitchell, DG; Mohamed, F; Ortega, H; Tascyian, T; Vinitski, S | 1 |
Foo, TK; Francis, IR; Low, RN; Sigeti, JS | 1 |
Bloem, JL; Eulderink, F; Geirnaerdt, MJ; Hogendoorn, PC; Taminiau, AH | 1 |
Beck, W; Haustein, J; Kaiser, W; Laniado, M; Louton, T; Niendorf, HP; Planitzer, J; Reiser, M; Schöffel, M; Schörner, W | 1 |
Matsubara, S; Nagase, M; Sugiyama, M; Takebayashi, S | 1 |
de Roos, A; Höld, KM; Holman, ER; Ozdemir, HI; van der Laarse, A; van der Nat, TH; van der Wall, EE; van Dijkman, PR | 1 |
Wolf, GL | 1 |
Chiu, L; Goldberg, RA; Heinz, GW | 1 |
Grandin, C; Levesque, M; Pringot, J; Soyer, P; Van Beers, B | 1 |
Barkley, GL; Mehta, BA; Sanders, WP; Silbergleit, R; Spickler, EM | 1 |
Bier, J; Felix, R; Garbe, C; Knollmann, FD; Mäurer, J; Schlums, D; Vogl, TJ | 1 |
Hieronim, DE; Kanal, E; Swanson, DP | 1 |
Adeleine, P; Berthezene, Y; Froment, JC; Nighoghossian, N; Philippon, B; Trouillas, P | 1 |
Combe, C; Degrèze, P; Douws, C; Gosse, P; Grenier, N; Jeandot, R; Palussière, J; Trillaud, H | 1 |
Honda, S; Nishiharu, T; Takahashi, M; Urata, J; Yamashita, Y | 1 |
Maeder, P; Meuli, RA | 1 |
Kleinman, PK; Ragland, RL | 1 |
Brossmann, J; Daenen, B; Preidler, KW; Resnick, D; Trudell, D; Wang, YC | 1 |
Budnick, RM; Herman, S; Klippenstein, DL; Stewart, CC; Stomper, PC; Winston, JS | 1 |
de Roos, A; Doesburg, T; Holman, ER; van der Wall, EE; van Rossum, AC; Visser, CA | 1 |
Weissleder, R | 1 |
Giovagnoni, A; Paci, E | 1 |
Alamar, R; Aznar, L; Campos, A; Castelló, JV | 1 |
Kinkel, K; Lasser, P; Rougier, P; Soyer, P; Spatz, A; Tardivon, AA; Vanel, D | 1 |
Bartl, R; Baur, A; Lamerz, R; Reiser, M; Stäbler, A | 1 |
Boer, WH; Fransen, R; Koomans, HA; Muller, HJ; Nicolay, K | 1 |
Lee, C; Runge, VM; Timoney, JF; Wells, JW; Williams, NM | 1 |
Elster, AD; Hamilton, CA; Mathews, VP; Moran, PR; Ulmer, JL | 1 |
Hackländer, T; Hofer, M; Mödder, U; Reichenbach, JR | 1 |
Bruening, R; Cher, L; Harsh, GR; Hochberg, FH; Kwong, KK; Niemi, PT; Rosen, BR; Vevea, MJ; Weisskoff, RM | 1 |
Egelhof, T; Essig, M; Sartor, K; von Kummer, R; Winter, R | 1 |
Kostick, D; Kotzan, JM; Ortiz, O; Schochet, SS | 1 |
McClarty, BM; McGinn, GJ; Steven, DA | 1 |
Buadu, LD; Hashiguchi, N; Kuroki, S; Masuda, K; Murakami, J; Murayama, S; Ohno, S; Sakai, S; Toyoshima, S | 1 |
Amin, Z; Bown, SG; Buonaccorsi, G; Davidson, TI; Hall-Craggs, MA; Kissin, MW; Mumtaz, H; Paley, M; Taylor, I; Wilkinson, I; Wotherspoon, A | 1 |
Bernard, PJ; Buchanan, EM; Dolan, RP; Lauffer, RB; McMurry, TJ; Midelfort, KS; Ong, KY; Ouellet, HS; Parmelee, DJ; Sajiki, H; Scott, DM; Tyeklár, Z; Walovitch, RC | 1 |
Bruneton, JN; Brunner, P; Chanalet, S; Huys, C; Michiels, JF; Mouroux, J; Padovani, B; Raffaelli, C | 1 |
Balkissoon, A | 1 |
La Noce, A; Miragoli, L; Samuelli, G; Tirone, P | 1 |
Baron, RL; Murakami, T; Peterson, MS | 1 |
Brix, G; Essig, M; Hawighorst, H; Hoffmann, U; Knapstein, PG; Knopp, MV; Schaeffer, U; Schönberg, S; van Kaick, G; Weikel, W; Zuna, I | 1 |
Crawley, AP; Gaul, HP; Wallace, CJ | 1 |
Brunberg, JA; Cloft, HJ; Murphy, KJ; Prince, MR | 1 |
Bakshi, R; Mazziotta, JC | 1 |
Awaya, H; Fujita, T; Honjo, K; Ito, K; Koike, S; Matsumoto, T; Matsunaga, N; Mitchell, DG; Takano, K | 1 |
Chan, KM; Galgiani, TN; Lund, PJ; Pitt, MJ; Unger, EC | 1 |
Damani, NN; Llewellyn, CG; Maloney, WJ; Salgado, MJ; Sangalang, VE; Vandorpe, RA | 1 |
Achten, C; Audretsch, W; Kurtz, B; Rezai, M; Zocholl, G | 1 |
Adam, G; Dick, A; Günther, RW; Mühler, A; Prescher, A; Spüntrup, E | 1 |
Runge, VM; Wells, JW; Williams, NM | 1 |
DeCorato, DR; Earls, JP; Johnson, G; Krinsky, G; Purdy, DE; Rofsky, NM; Weinreb, JC | 1 |
Colvin, SB; DeCorato, DR; Earls, JP; Flyer, MA; Galloway, AC; Krinsky, GA; Rofsky, NM; Weinreb, JC | 1 |
Bis, KG; Ellwood, RA; Kirsch, MJ; Konez, O; Shetty, AN; Shirkhoda, A | 1 |
DeCorato, DR; Earls, JP; Krinsky, GA; Rofsky, NM; Weinreb, JC | 1 |
Gordon, P; Hugo, F; Lundby, B | 1 |
Becherer, A; Gnant, M; Helbich, TH; Kelkar, P; Leitha, T; Mostbeck, GH; Rudas, M; Seifert, M; Staudenherz, A; Trattnig, S; Wolf, G | 1 |
Bergin, CJ; Bloor, C; Buxton, R; Hauschildt, J; Huynh, TV; Konopka, RG | 1 |
Kimura, M; Sakai, K; Seki, H | 1 |
Ehrhardt, K; Heintzen, P; Köhnlein, S; Kuhtz-Buschbeck, JP; Radtke, W | 1 |
Good, RB; May, DA; Parsons, TW; Smith, DK | 1 |
Bluemke, DA; Frassica, FJ; Ma, LD; McCarthy, EF; Zerhouni, EA | 1 |
Adjei, ON; Flores, LG; Futami, S; Jinnouchi, S; Kodama, T; Murakami, N; Nagamachi, S; Nakahara, H; Noguchi, S; Ohnishi, T; Tamura, S; Watanabe, K | 1 |
Skalpe, IO; Tang, GJ | 1 |
Gentili, A; Seeger, LL; Yao, L | 1 |
García, N; Gonzalez del Valle, L; Jiménez, E; Ramón, E; Ruano, M | 1 |
Cho, KJ; Johnson, DB; Kazanjian, SN; Leichtman, AB; Lerner, CA; Narasimham, DL; Prince, MR | 1 |
Bøkenes, J; Hustvedt, SO; Refsum, H | 1 |
Akre, BT; Dunkel, JA; Hustvedt, SO; Refsum, H | 1 |
Chenevert, TL; Foo, TK; Londy, FJ; Maki, JH; Prince, MR; Ward, JS | 1 |
Claussen, CD; Dietz, K; Müller-Schimpfle, M; Ohmenhaüser, K; Stoll, P | 1 |
Amundsen, T; Bjermer, L; Haraldseth, O; Jones, RA; Kvaerness, J; Nilsen, G; Waage, A | 1 |
Kondo, T; Kuruma, H; Kusano, S; Murakami, T; Tsushima, Y | 1 |
Bensahel, H; Ducou Le Pointe, H; Hassan, M; Klein, I; Maiza, D; Mazda, K; Sebag, G | 1 |
Baba, T; Baba, Y; Furusawa, M; Ishikawa, T; Murakami, R; Nishimura, R; Okuda, T; Takahashi, M | 1 |
Burman, P; Edén Engström, B; Karlsson, FA; Lundin, P | 1 |
Alhassan, A; Weinmann, HJ | 1 |
Barkhof, F; Hoogenraad, F; Peeters, J; Smeets, M; Tan, KE; Valk, J; van der Valk, P | 1 |
Adler, A; Felix, R; Hammerstingl, R; Hintze, R; Hünerbein, M; Lobbeck, H; Mack, MG; Pegios, W; Schlag, P; Vogl, TJ; Wust, P | 1 |
Chandnani, VP; Helgason, JW; Yu, JS | 1 |
Azumi, R; Kimura, M; Sakai, K; Seki, H | 1 |
Barentsz, JO; de la Rosette, JJ; Jager, GJ; Oosterhof, GO; Ruijs, SH; Ruijter, ET; Thornbury, JR; van de Kaa, CA | 1 |
Blakeborough, A; Griffiths, M; Guthrie, JA; Kajiya, Y; Robinson, PJ; Ward, J; Wilson, D | 1 |
Amin, MB; Bouffard, JA; Craig, JG; Eyler, WR; Shirazi, K; van Holsbeeck, MT; Wu, K | 1 |
Bendib, K; Berthezène, Y; Bertocchi, M; Croisille, P; Houzard, C; Revel, D | 1 |
Adam, G; Günther, RW; Kilbinger, M; Staatz, G | 1 |
Atilla, S; Borrello, JA; Brown, JJ; Pilgram, TK; Quillin, SP; Yu, CY | 1 |
Bazari, H; Cambria, RP; Fang, LS; Geller, SC; Kaufman, JA; Rieumont, MJ; Waltman, AC; Yucel, EK | 1 |
deSouza, NM; Gilderdale, DJ; MacIver, DK; Ward, HC | 1 |
Brix, G; Engenhart, R; Essig, M; Fuss, M; Grandy, M; Hawighorst, H; Knopp, MV; Miltner, P; van Kaick, G; Zuna, I | 1 |
Agen, C; Bartolozzi, C; Caramella, D; Jin, XN; Mascalchi, M; Nardini, D; Petruzzi, P; Tessa, C | 1 |
Debatin, JF; Hany, TF; Leung, DA; Pfammatter, T | 1 |
Christensen, BV; Huang, Y; Jerosch-Herold, M; McDonald, K; Stillman, AE; Ugurbil, K; Wang, Y; Wilke, N; Wilson, RF | 1 |
Alzate, GD; Barone, RM; Lacey, C; Low, RN; Sebrechts, CP; Sigeti, JS | 1 |
Choi, BI; Han, JK; Han, MC; Jang, HJ; Kim, TK | 1 |
Blum, AL; Dorta, G; Uske, A | 1 |
Cherryman, GR; Horsfield, MA; Jivan, A; Moody, AR | 1 |
Gouhiri, M; Rondeau, Y; Rymer, R; Scherrer, A; Soyer, P; Spelle, L | 1 |
Melloni, P; Valls, R | 1 |
Sundaram, M | 1 |
Lee, C; Runge, VM; Williams, NM | 1 |
Francis, IR; Low, RN | 1 |
Hall, FM; Prasad, PV | 1 |
Adelman, MA; Johnson, G; Krinsky, GA; Rofsky, NM; Rosen, RJ; Weinreb, JC | 1 |
Faber, SC; Gauger, J; Helmberger, T; Holzknecht, N; Reiser, M; Stehling, MK | 1 |
Debatin, JF; Erhart, P; Flury, R; Klotz, HP; Largiadèr, F; Steiner, P; Uhlschmid, G | 1 |
Castelli, PM; Cavagna, FM; Daprà, M; Kirchin, MA; Maggioni, F | 1 |
Diebold, T; Felix, R; Hammerstingl, R; Lodemann, KP; Mack, M; Neuhaus, P; Pegios, W; Stupavsky, A; Vogl, TJ | 1 |
Cavagna, FM; Derugin, N; Geschwind, JF; Higgins, CB; Lauerna, K; Mintorovitch, J; Saeed, M; Sakuma, H; Wendland, MF | 1 |
Buisseret, TS; Coen, HL; Lee, RR; Neirynck, EC; Osteaux, MJ; Stadnik, TW | 1 |
Kopp, AF; Laniado, M | 1 |
Caduff, RF; Debatin, JF; Garzoli, E; Kacl, GM; Krestin, GP; Liu, P | 1 |
Caramia, F; Cavagna, FM; Hamberg, LM; Huang, Z; Moskowitz, MA; Rosen, BR; Weisskoff, RM; Zaharchuk, G | 1 |
Skalpe, IO | 1 |
Davies, A; Kirchin, M; Lorusso, V; Pirovano, G; Spinazzi, A; Taroni, P | 1 |
Benderbous, S; Canet, E; Casali, C; Corot, C; Janier, M; Obadia, JF; Revel, D | 1 |
Arbughi, T; Bertani, F; Celeste, R; Grotti, A; Sillari, S; Tirone, P | 1 |
Kirchin, MA; Pirovano, GP; Spinazzi, A | 1 |
Alnot, JY; Benacerraf, R; Chevrot, A; Drapé, JL; Houvet, P; Silbermann-Hoffman, O; Tardif-Chastenet de Gery, S | 1 |
Bremerich, J; Canet, E; Higgins, CB; Saeed, M; Sakuma, H; Schwitter, J; Wendland, MF | 1 |
Demicheli, F; Frigeni, V; La Noce, A; Miragoli, L; Tirone, P | 1 |
Itai, Y | 1 |
Baron, RL; Cotroneo, AR; De Franco, A; De Gaetano, AM; Manfredi, R; Marano, P; Maresca, G; Pirovano, G; Spinazzi, A | 1 |
Bensel, K; Davies, BE; LaFrance, ND; Lambrecht, LJ; McCloud, S; Parker, JR; Swan, SK; Townsend, R | 1 |
Benderbous, S; de Roos, A; Doornbos, J; Kroft, LJ; van der Geest, RJ | 1 |
Bautz, W; Dobritz, M; Fellner, C; Fellner, F; Janka, R; Lang, W; Lenz, M | 1 |
Danieli, A; Filatori, I; Frigeni, V; La Noce, A; Tirone, P | 2 |
Kirchin, MA; La Noce, A; Pirovano, G; Ruscalleda, J; Spinazzi, A | 1 |
Clément, O; Cuénod, CA; Frija, G; Leconte, I; Siauve, N; Vuillemin-Bodaghi, V | 1 |
Hamm, B; Kirchin, M; Pirovano, G; Spinazzi, A | 1 |
Grazioli, L; Kirchin, M; Pirovano, G; Spinazzi, A | 1 |
Hirohashi, S; Kadoya, M; Katayama, H; Kuwatsuru, R; Murakami, T; Ohtomo, K; Tanaka, Y; Tanimoto, A; Yoshikawa, K | 2 |
Bartolozzi, C; Spinazzi, A | 1 |
Akhnana, L; Cabrini, M; Calabi, L; de Haën, C; Gozzini, L; Ratti, D | 1 |
de Haën, C; La Ferla, R; Maggioni, F | 1 |
Arbughi, T; de Haën, C; Lorusso, V; Tirone, P | 1 |
Castano, M; Cipolla, P; de Haën, C; Frigeni, V; La Noce, A; Luzzani, F; Tirone, P; Valenti, R | 1 |
Bussi, S; de Haën, C; Morisetti, A; Tirone, P | 1 |
Bussi, S; Chimoto, T; Morisetti, A; Sagami, F; Tirone, P | 1 |
Bussi, S; Masters, RE; Morisetti, A; Sagami, F; Sekido, T; Tirone, P | 1 |
Aoki, T; Bussi, S; Masters, RE; Morisetti, A; Sagami, F; Tirone, P | 1 |
Bussi, S; Katsutani, N; Mandella, RC; Morisetti, A; Sagami, F; Tirone, P | 1 |
Baguley, JK; Bussi, S; Morisetti, A; Okada, F; Sagami, F; Tirone, P | 1 |
Baguley, JK; Bussi, S; Kawaguchi, T; Morisetti, A; Sagami, F; Tirone, P | 1 |
Bussi, S; Masters, RE; Morisetti, A; Okuda, Y; Sagami, F; Tirone, P | 1 |
Bussi, S; Fassio, F; Hakura, A; Morisetti, A; Sagami, F; Tirone, P | 1 |
Adams, K; Bussi, S; Daimon, H; Morisetti, A; Sagami, F; Sawada, S; Tirone, P; Toritsuka, N | 1 |
Bussi, S; Daimon, H; Fassio, F; Morisetti, A; Sagami, F; Sawada, S; Tirone, P; Toritsuka, N | 1 |
Bussi, S; Goto, K; Kimura, H; Mikami, T; Morisetti, A; Sagami, F; Tirone, P; Yamada, Y | 1 |
Benetti, A; Caudana, R; Colombari, R; Grazioli, L; Kirchin, MA; Morana, G; Pirovano, G; Portolani, N; Spinazzi, A; Talamini, G | 1 |
Carlsen, RC; Gorin, FA; McBride, TA; Stockert, BW | 1 |
Bonnemain, B; Bourrinet, P; Corot, C; Dencausse, A; Devoldere, L; Foulon, M; Lin, J; Meyer, D; Port, M; Raynal, I; Rousseaux, O; Schaefer, M; Simonot, C | 1 |
Bartolozzi, C; Bloem, JL; Chiesa, A; Claussen, C; Daldrup, HE; Giovagnoni, A; Grazioli, L; Greco, A; Hamm, B; Heuck, A; Kirchin, MA; Laniado, M; Lencioni, R; Manfredi, R; Marano, P; Marchal, G; McNamara, MT; Petersein, J; Petre, C; Pirovano, G; Reiser, M; Rummeny, E; Soyer, P; Spinazzi, A; Terrier, F; Van Persijn Van Meerten, EL | 1 |
Castano, M; Cipolla, P; Garribba, D; Tirone, P | 1 |
Imai, M; Ishibashi, K; Miyoshi, T; Murata, M; Ohki, G; Suzuki, M | 1 |
Ferreira, LM; Parodi, JC | 1 |
Brochard, T; Charvet, AM; Collomb, A; Corde, S; Elleaume, H; Estève, F; Fiedler, S; Le Bas, JF; Le Duc, G | 1 |
Bensel, K; Cohen, DL; Davies, BE; Katholi, R; Lambrecht, L; Parker, J; Swan, SK; Townsend, RR | 1 |
Barros, LF; Calixto, A; Castro, J; Catalán, M; Hermosilla, T; Hetz, C; Stutzin, A | 1 |
Bourne, M; Gehl, HB; Grazioli, L; Lodemann, KP; Möller, A | 1 |
Armstrong, MR; Barr, RG; Berger, BL; Czervionke, LF; Gonzalez, CF; Halford, HH; Kanal, E; Kuhn, MJ; Levin, JM; Low, RN; Runge, VM; Tanenbaum, LN; Wang, AM; Wong, W; Yuh, WT; Zoarski, GH | 1 |
Colosimo, C; Kirchin, MA; Korves, M; La Ferla, R; Pianezzola, P; Ruscalleda, J; Wool, C | 1 |
Allkemper, T; Heindel, W; Tombach, B | 1 |
Belhadj, K; Divine, M; Gaulard, P; Golli, M; Jazaerli, N; Lepage, E; Rahmouni, A; Reyes, F; Vasile, N | 1 |
Carpenter, E; Peers, C | 1 |
Frigeni, V; Grotti And, A; Lorusso, V; Miragoli, L | 1 |
Giesel, FL; Knopp, MV; Radeleff, J; Von Tengg-Kobligk, H | 1 |
Claassen, G; Corot, C; Dewey, M; Hamm, B; Kivelitz, D; Robert, P; Rogalla, P; Schnorr, J; Taupitz, M; Wagner, S | 1 |
Helmberger, T; Semelka, RC | 1 |
Balériaux, D; Bohndorf, K; Bongartz, G; Bourne, MW; Cherryman, GR; Colosimo, C; Kirchin, MA; Korves, M; La Noce, A; Parizel, PM; Pirovano, G; Reiser, M; Ruscalleda, J; Salerio, I; Sartor, K; Schneider, G; Spinazzi, A; van Buchem, MA | 1 |
Benoit, Y; Mortelé, B; Mortelé, KJ; Ros, PR; Vanzieleghem, B | 1 |
Cotten, A; Demondion, X; Drizenko, A; Francke, JP; Lapègue, F; Leroy, X | 1 |
Barkhausen, J; Bosk, S; Debatin, J; Goyen, M; Herborn, CU; Lauenstein, TC; Ruehm, SG; Veit, P | 1 |
Bensel, K; Davies, A; Davies, BE; Kirchin, MA; Lafrance, ND; Lorusso, V; Parker, JR | 1 |
Bigot, JM; Boudghene, F; Deux, JF; Le Blanche, AF; Rossert, J; Tassart, M | 1 |
Barentsz, JO; Bonomo, L; Daprà, M; del Maschio, A; Grabbe, E; Hamm, B; Hentrich, HR; Kirchin, MA; Knopp, MV; Kroencke, TJ; Marchal, G; Pattynama, PM; Pennell, DJ; Schneider, G; Spinazzi, A; Taupitz, M; Wasser, MN | 1 |
Bazzocchi, M; Como, G; del Frate, C; Londero, V; Mortele, KJ; Ros, PR; Zanardi, R; Zuiani, C | 1 |
Fujimori, Y; Iida, H; Iwasawa, K; Jo, T; Morita, T; Nagai, R; Nakajima, T; Nakamura, F; Oonuma, H; Terasawa, K; Toyo-oka, T | 1 |
Bosk, S; Debatin, JF; Goyen, M; Herborn, CU; Lauenstein, TC; Ruehm, SG | 1 |
Düx, M; Fink, C; Hallscheidt, PJ; Hosch, WP; Kauffmann, GW; Ott, RC; Wiesel, M | 1 |
Corot, C; de Roos, A; Dirksen, MS; Kunz, P; Lamb, HJ; Robert, P | 1 |
Cademartiri, F; Luccichenti, G; Lucidi, V; Marchesi, G; Pavone, P; Ugolotti, U | 1 |
Biondi, L; Calabi, L; De Miranda, M; Ghelli, S; Guillou, C; Paleari, L; Reniero, F | 1 |
Ahlström, H; Barentsz, JO; Bonomo, L; Daprà, M; Del Maschio, A; Hamm, B; Hentrich, HR; Kirchin, MA; Knopp, MV; Marchal, G; Oudkerk, M; Pattynama, PM; Shen, N; Spinazzi, A; Wasser, MN; Wikström, J | 1 |
Lorusso, V; Mayer, J; Montet, X; Pastor, CM; Planchamp, C; Pochon, S; Terrier, F; Vallee, JP | 1 |
Barantin, L; Bertrand, P; Bleuzen-Couthon, A; Cottier, JP; Domengie, F; Gallas, S; Herbreteau, D; Vinikoff-Sonier, CB | 1 |
Barbiera, F; Bencivinni, F; Cannizzaro, F; Caronia, A; La Tona, G; Lo Casto, A; Rossello, M; Salerno, S | 1 |
Arlart, IP; Gerlach, A; Hatopp, A; Klinger, S; Prodehl, P; von Kalle, T | 1 |
Reimer, P; Schima, W; Schneider, G | 1 |
Essig, M | 1 |
Ahlhelm, F; Böhm, M; Fries, P; Kindermann, I; Kramann, B; Schneider, G | 1 |
Debatin, JF; Goyen, M | 1 |
Balant, L; Dornier, C; Gex-Fabry, M; Ivancevic, MK; Meier, PJ; Pastor, CM; Planchamp, C; Pochon, S; Quadri, R; Reist, M; Stieger, B; Terrier, F; Vallée, JP | 1 |
Cavagna, F | 1 |
Anserini, P; Castelletti, L; De Caro, G; Ferraiolo, A; Gorlero, F | 1 |
Christophe, C; Colosimo, C; Demaerel, P; Högström, B; Kirchin, MA; Pirovano, G; Shen, N; Spinazzi, A; Tortori-Donati, P; Van Buchem, M | 1 |
Tavares, NJ; Thomas, B | 2 |
Kim, HJ; Kim, MD; Kim, NK; Lee, MH; Park, HR; Park, WK; Yoon, SW | 1 |
Debatin, JF; Goyen, M; Herborn, CU; Lauenstein, TC; Ruehm, SG; Vogt, FM | 1 |
Bornstedt, A; Fleck, E; Gebker, R; Gomaa, O; Jahnke, C; Nagel, E; Neuss, M; Paetsch, I; Schnackenburg, B | 1 |
Choi, JS; Kim, JH; Kim, KW; Kim, MJ; Kim, SI; Lee, JT; Lim, JS; Oh, YT; Park, MS; Yoo, HS | 1 |
Corot, C; Gagneur, G; Port, M; Raynal, I; Robert, P; Violas, X | 1 |
Fiocchi, F; Nasi, F; Pecchi, A; Rivasi, F; Torricelli, P | 1 |
Andreisek, G; Ess, S; Fröhlich, JM; Nanz, D; Pfammatter, T; Treiber, K; Weishaupt, D | 1 |
Cova, MA; Cuttin-Zernich, R; Gava, S; Grisi, G; Lubin, E; Pozzi-Mucelli, F; Stacul, F | 1 |
Cotton, F; Gilly, FN; Glehen, O; Granier, A; Pellet, O; Sournac, L | 1 |
Ward, J | 1 |
Bussi, S; Fouillet, X; Morisetti, A | 1 |
Grgic, A; Heckmann, MB; Heinrich, MC; Kohlbacher, S; Kuhlmann, MK; Scheer, M; Uder, M | 1 |
Sinha, R; Verma, R | 1 |
Rummeny, EJ; Settles, M; Weirich, G; Wiener, E; Woertler, K | 1 |
Albiin, N; Brismar, TB; Dahlström, N; Persson, A; Smedby, O | 1 |
Ahlström, H; Johansson, L; Karacagil, S; Wikström, J | 1 |
Barboriak, DP; Dale, BM; Merkle, EM | 1 |
Broome, DR; Kanal, E; Martin, DR; Thomsen, HS | 1 |
Demir, MK; Genchellac, H; Ozdemir, H | 1 |
Clément, O | 1 |
Sardanelli, F | 1 |
Endo, K; Takahashi-Taketomi, A; Tsushima, Y | 1 |
Bonanno, E; Carlani, M; Finazzi Agrò, E; Mancino, S; Simonetti, G | 1 |
Corot, C; Idée, JM | 1 |
Avelino-Cruz, JE; Berra Romani, R; Coltrini, D; Laforenza, U; Milesi, V; Moccia, F; Oldani, A; Raqeeb, A; Scaffino, MF; Taglietti, V; Tanzi, F | 1 |
Bilecen, D; Bongartz, G; Gluecker, T; Jacob, AL; Reisinger, C | 1 |
Badero, OJ; Rizk, D; Schlanger, L | 1 |
Apajalahti, S; Hagström, J; Kuhlefelt, M; Suomalainen, A | 1 |
Barkhausen, J; Breuckmann, F; Hunold, P; Nassenstein, K; Schlosser, T | 1 |
Iezzi, R; Kirchin, MA; Pirovano, G; Schneider, G; Shen, N; Soulez, G; Spinazzi, A; Thurnher, S | 1 |
Bousquet, PJ; Cavigioli, S; Demoly, P; Galera, C; Pur Ozygit, L | 1 |
Bley, TA; Bock, J; Burkhardt, H; Frydrychowicz, A; Hennig, J; Markl, M; Stalder, AF | 1 |
Chrysochou, C; Husain, S; Kalra, PA; Lay, J; Moser, S; Power, A; Salama, AD; Shurrab, AE | 1 |
Förster, A; Gass, A; Griebe, M; Hennerici, MG; Kern, R; Ottomeyer, C; Szabo, K; Wolf, ME | 1 |
Anzalone, N | 1 |
Jia, G; Knopp, MV; Liang, J; Sammet, S; Takayama, Y; Yang, X | 1 |
Carbone, I; Francone, M; Iacucci, I; Mangia, M | 1 |
Aschauer, M; Ballarati, C; Bilecen, D; Iezzi, R; Konopka, M; Pasowicz, M; Schneider, G; Seidl, Z; Vymazal, J | 1 |
Burden, AD; Edward, M; Jardine, AG; Newton, BB; Quinn, JA | 1 |
Amelia, R; Bonomo, L; Bosello, S; D'Antona, G; Ferraccioli, G; Leone, A; Magarelli, N; Simone, F; Zoli, A | 1 |
Liu, NF; Lu, Q; Yan, ZX | 1 |
Botnar, RM; Brinker, G; Ernestus, RI; Jacobs, JE; Kleimann, JF; Lackner, KJ; Loehr, M; Möller-Hartmann, W; Poggenborg, J; Spuentrup, E; Wiethoff, AJ | 1 |
Perazella, MA; Reilly, RF | 1 |
Nouh, MR; Ragatte, RR; Schweitzer, ME | 1 |
Brill, PW; Prince, MR; Staron, RB; Zhang, H; Zou, Z | 1 |
Caysa, H; Mäder, K; Metz, H; Mueller, T | 1 |
Boué, F; Bruckert, F; Combe, S; Dempsey, NM; Gaude, V; Haguet, V; Ith, A; Kauffmann, P; O'Brien, D; Reyne, G; Schaack, B | 1 |
Coss, M; Cova, MA; De Manzini, N; De Paoli, L; De Pellegrin, A; Quaia, E; Ukmar, M; Ulcigrai, V; Zanconati, F | 1 |
Lu, Q; Wei, X; Wu, H; Xu, J; Xu, Y | 1 |
Bluemke, DA; Jones, J; Kawel, N; Liu, S; Nacif, M; Sibley, CT; Zavodni, A | 1 |
Cerna, M; Herman, M; Hrdina, L; Kocher, M; Kozak, J; Langova, K; Mahathmakanthi, S; Tudos, Z | 1 |
Grosse-Wortmann, L; Meng, H | 1 |
Chandramohan, S; Christie, A; Roditi, G | 2 |
Ah Ryu, J; Choi, JH; Choi, SH; Ho Kim, S; Jeong, WK; Kim, J; Lee, S | 1 |
Chandrasekharan, P; Chuang, KH; He, T; He, Z; Liu, S; Poh, Z; Robins, EG; Yang, CT; Yong, CX | 1 |
Chung, KK; Donaldson, PJ; Gunning, SJ; Webb, KF | 1 |
Jakubowski, N; Lindner, U; Lingott, J; Panne, U; Richter, S | 1 |
Dahi, F; Jiang, Y; Oto, A; Rist, C; Schmid-Tannwald, C; Sethi, I | 1 |
Bluemke, DA; Cater, G; Gai, N; Jones, J; Li, D; Liu, S; Nacif, MS; Raman, FS; Sibley, CT | 1 |
Ariff, B; Bai, W; Boubertakh, R; Davies, DW; Francis, DP; Hunter, R; Jamil-Copley, S; Jones, D; Juli, C; Kanagaratnam, P; Karim, R; Kojodjojo, P; Lim, PB; Malcolme-Lawes, LC; Peters, NS; Petersen, SE; Quest, R; Rueckert, D; Schilling, R | 1 |
Chaudhuri, A | 1 |
Dehkharghani, S; Kang, J; Saindane, AM | 1 |
Dixon, LJ; Hamilton, A; Horan, P; Johnston, N; Lyons, KS; McKeag, N; Noad, R | 1 |
Bender, D; Bloess, K; Burkholder, I; Kauczor, HU; Schmidmaier, G; Schoierer, O; Weber, MA | 1 |
Arimura, H; Hayashida, E; Oda, S; Okigawa, T; Okumura, S; Sasao, A; Tajiri, S; Urata, J; Utsunomiya, D; Wada, H; Yamashita, Y | 1 |
Fox, MG; Gaskin, CM; Huynh, BH; Patrie, JT; Ugas, MA | 1 |
Andreisek, G; Boss, A; Chuck, NC; Curcio, R; Froehlich, JM; Goetschi, S; Nanz, D; Runge, VM | 1 |
Doltra, A; Fleck, E; Gebker, R; Hamdan, A; Kelle, S; Klein, C; Nagel, E; Schnackenburg, B; Skorin, A | 1 |
Corot, C; Factor, C; Fretellier, N; Idée, JM; Mayer, JF; Medina, C; Port, M; Poteau, N | 1 |
Amarteifio, E; Attigah, N; Böckler, D; Demirel, S; Essig, M; Schuster, L | 1 |
Bamra, VR; Camren, GP; Hippe, DS; Maki, JH; Nguyen, KQ; Wilson, GJ | 1 |
Abu Alfa, AK; Bauer, K; Belknap, SM; Bhatt, K; Bull, C; Cowper, SE; Edwards, BJ; Fisher, MJ; Hammel, JA; Kanal, E; Laumann, AE; McKoy, JM; Miller, FH; Nardone, B; Raisch, DW; Restaino, J; Saddleton, E; Samaras, AT; Thomsen, HS; West, DP | 1 |
Abujudeh, HH; Aran, S; Shaqdan, KW | 1 |
Parikh, MR; Perez, SD; Runge, TM; Sakaria, SS; Shaffer, KM; Subramanian, RM | 1 |
Ben-David, E; Chaushu, S; Dykstein, N; Friedlander-Barenboim, S; Gomori, JM; Shalish, M | 1 |
Kanal, E; Tweedle, MF | 1 |
Hernando, D; Reeder, SB; Smith, MR | 1 |
Platas-Iglesias, C; Regueiro-Figueroa, M | 1 |
Abujudeh, HH; Bloomgarden, DC; Kirchin, MA; Kuhn, MJ; Lichtenstein, RJ; Liou, J; Maki, JH; Mennitt, KW; Morgan, DE; Pirovano, G; Rofsky, NM; Russo, C; Schiebler, ML; Semelka, RC; Shen, N; Smith, MP; Soulez, G; Spinazzi, A; Stolpen, A; Wippold, FJ | 1 |
Bley, TA; Fischer, A; Köstler, H; Kunz, AS; Oechsner, M; Ritter, CO; Veldhoen, S; Weng, AM | 1 |
Kay, J; Todd, DJ | 1 |
Dills, R; Fligner, C; Gonzalez-Cuyar, LF; Hippe, D; Maravilla, KR; Murata, K; Murata, N | 1 |
AlObaidy, M; Castillo, M; Nunes, RH; Ramalho, J; Ramalho, M; Semelka, RC | 1 |
Bazzocchi, M; Fongione, S; Girometti, R; Pancot, M; Pullini, S; Signor, MA; Zuiani, C | 1 |
Liu, L; Peck Palmer, OM; Tamama, K | 1 |
Lancelot, E | 1 |
Brown, JJ; Moritz, M; Neeley, C; Zhou, Y | 1 |
Bohmart, A; Cao, Y; Hecht, EM; Prince, MR; Shih, G; Zhang, Y | 1 |
Bastawrous, S; Maki, JH; Springer, CS; Wilson, GJ | 1 |
Annapragada, A; Bhavane, R; Gao, H; Ghaghada, K; Lee, W; Patel, C; Pautler, R; Rendon, D; Shetty, AN; Starosolski, Z; Yallampalli, C | 1 |
Bendszus, M; Hepp, J; Kickingereder, P; Kieslich, PJ; Radbruch, A; Schlemmer, HP; Weberling, LD; Wick, W | 1 |
AlObaidy, M; Burke, LM; Jay, M; Ramalho, J; Ramalho, M; Semelka, RC; Vakharia, A | 1 |
Deng, J; Johnson, JT; Rigsby, CK; Robinson, JD | 1 |
Jay, M; Prybylski, JP; Semelka, RC | 1 |
Berglin, CE; Counter, SA; Damberg, P; Laurell, G; Nikkhou-Aski, S | 1 |
Antoch, G; Caspers, J; Klee, D; Rademacher, C; Schaper, J; Tibussek, D; Turowski, B | 1 |
Alonso, A; Eisele, P; Gass, A; Ong, M; Platten, M; Schoenberg, SO; Szabo, K | 1 |
Furui, S; Hagiwara, A; Kanda, T; Nakai, Y; Oba, H; Toyoda, K | 1 |
Bourrinet, P; de Buttet, S; Felices, M; Jurkiewicz, E; Koob, M; Scala, M | 1 |
Amano, I; Erdene, K; Kameo, S; Khairinisa, MA; Koibuchi, N; Koyama, H; Nakajima, T; Takatsuru, Y; Tsushima, Y | 1 |
Barile, A; Di Cesare, E; Marsecano, C; Michelini, G; Perri, M; Splendiani, A; Vellucci, V | 1 |
Glockner, JF; Lee, CU; Mounajjed, T | 1 |
Bonafè, R; Botteron, C; Bussi, S; Celeste, R; Coppo, A; Kirchin, MA; Maisano, F; Penard, L; Queliti, R; Tedoldi, F | 1 |
Cheon, JE; Choi, YH; Kim, IO; Kim, WS; Lee, WJ; Park, JE; Park, S; Ryu, YJ | 1 |
Dickerson, JM; Dillman, JR; Forbes-Amrhein, MM; Giordano, RM; Koch, BL; Towbin, AJ; Trout, AT | 1 |
Miller, FH; Mozaffary, A; Schmitz, B; Sodagari, F; Wood, CG; Yaghmai, V | 1 |
Darmon-Kern, E; Desché, P; Lancelot, E; Laurent, AC; Raynaud, JS | 1 |
Splendiani, A | 1 |
Celiker, FB; Celiker, M; Coskun, ZO; Dursun, E; Mercantepe, T; Oghan, F; Terzi, S; Tumkaya, L; Yilmaz, A | 1 |
Cho, H; Jin, S; Kang, M | 1 |
Frank, MS; Kralik, SF; Ladd, LM; Singhal, KK | 1 |
Houston, JG; Matthew, SZ; Young, LK | 1 |
Gorelik, Y; Heyman, SN; Khamaisi, M; Yaseen, H | 1 |
Carrillo-Martin, I; Gonzalez-Estrada, A; Kesler, AM; Rodriguez-Nava, G | 1 |
Chauny, JM; Desjardins, A; Desnoyers, M; Irislimane, Y; Lambert, J; Lanthier, C; Maki, JH; Papas, K; Paul Finn, J; Pressacco, J; Samson, P; Toporowicz, K | 1 |
Al Saleh, T; Baalbaki, M; Chehabeddine, L; Hannoun, S; Khoury, SJ; Saleh, E | 1 |
Fan, DX; Hua, ZX; Ren, K; Wang, ST; Zhang, X | 1 |
Fingerhut, S; Henze, N; Jeibmann, A; Karst, U; Martin, LF; Paulus, W; Radbruch, A; Richter, H; Sperling, M; Xia, A | 1 |
Asbach, P; Hamm, B; Lee, CH; Taupitz, M; Vellayappan, B | 1 |
Hartman, RP; Hunt, CH; Kallmes, DF; Kolbe, AB; Maddox, DE; McDonald, JS; McDonald, RJ; Schmitz, JJ | 1 |
Allgeier, J; Arentz, T; Chen, J; Cochet, H; Haissaguerre, M; Hocini, M; Jadidi, A; Jais, P; Kim, S; Kohl, P; Lehrmann, H; Minners, J; Moreno-Weidmann, Z; Müller-Edenborn, B; Trenk, D | 1 |
Fochler, F; Kheirkahan, M; Kholmovski, EG; Marrouche, NF; Morris, AK; Yamaguchi, T | 1 |
Aime, S; Atlante, S; Di Gregorio, E; Furlan, C; Gianolio, E; Stefania, R | 1 |
Davenport, MS; Gagnier, JJ; MacEachern, MP; Shankar, PR; Singer, L; Woolen, SA | 1 |
Anderson, CE; Brady-Kalnay, SM; Clark, H; Darrah, RJ; Drumm, ML; Erokwu, BO; Flask, CA; Griswold, MA; Gu, Y; Hu, H; Johansen, M; Kavran, M; Li, M; Steinmetz, NF; Vincent, J; Yu, X; Zhang, Y | 1 |
Comby, PO; Corot, C; Factor, C; Grindel, AL; Lobinski, R; Robert, P; Strzeminska, I; Szpunar, J | 1 |
Bukte, Y; Semiz Oysu, A; Topcuoglu, ED; Topcuoglu, OM | 1 |
Forget, J; Maeder, P; Meuli, RA; Pozeg, P | 1 |
Frenzel, T; Jost, G; Knobloch, G; Pietsch, H | 1 |
Bechrakis, N; Deike-Hofmann, K; Forsting, M; Kleinschnitz, C; Radbruch, A; Schlemmer, HP; von Lampe, P | 1 |
Mehravi, B; Mohammadi, E; Mohseni, M; Shojaei, S | 1 |
Chanloi, C; Jindachai, N; Kothan, S; Moungthong, P; Supawat, B; Tima, S; Tungjai, M; Udomtanakunchai, C | 1 |
Bal, C; Clotagatide, A; Crémillieux, Y; Ichinose, N; Leclerc, L; Lux, F; Montigaud, Y; Perinel, S; Pinaud, N; Pourchez, J; Prevot, N; Tillement, O; Zhang, B | 1 |
Baranyai, Z; Brücher, E; Chianale, F; Colombo Serra, S; Giorgini, A; Giovenzana, GB; Guidolin, N; Kirchin, MA; Lotti, S; Maisano, F; Tedoldi, F; Travagin, F; Vágner, A | 1 |
Bageac, D; DeBevits, JJ; Dhib-Jalbut, S; DiCamillo, PA; Hu, C; Kaplan, J; Karimeddini, D; Munbodh, R; Naismith, RT; Wang, Y; Wolansky, L; Wu, R | 1 |
Kalantari, K; Swaminathan, S | 1 |
Cheon, J; Cheong, J; Choi, BW; Jung, JY; Kang, S; Kim, PK; Kim, S; Lah, JD; Lim, Y; Shin, TH; Shin, W | 1 |
Alcázar, A; Fraga, P; Jakobsen, JÅ; Müller, FHH; Outteryck, O; Panebianco, V; Pietura, R; Quattrocchi, CC; Reith, W; Sampedro, A | 1 |
Bonafè, R; Bussi, S; Colombo Serra, S; Coppo, A; Kirchin, MA; Maisano, F; Penard, L; Rossi, S; Tedoldi, F | 1 |
Liang, X; Yeh, CH | 1 |
Kanal, E | 1 |
Gonzalez-Cuyar, LF; Hasegawa, M; Hippe, DS; Kobayashi, M; Levendovszky, SR; Maravilla, KR; Marshall, DA; Murata, K; Murata, N | 1 |
Baltzer, PAT; Burke, CJ; Hellmich, M; Krug, KB; Maintz, D; Rhiem, K; Schlamann, M; Weiss, K | 1 |
Catoen, S; Corot, C; Factor, C; Idée, JM; Rasschaert, M; Robert, P; Santus, R; Violas, X | 1 |
Schröder, L; Schuenke, P; Taupitz, M; Werner, P | 1 |
Corot, C; Factor, C; Jimenez-Lamana, J; Lacomme, S; Le Coustumer, P; Lobinski, R; Robert, P; Schaumlöffel, D; Strzeminska, I; Subirana, MA; Szpunar, J | 1 |
Chanana, P; Ghobrial, RM; Kloc, M; Suarez-Villagran, M; Uosef, A; Vaughn, N; Wosik, J | 1 |
Joseph, A; Lancelot, E; Shahid, I | 1 |
Heshmatzadeh Behzadi, A; McDonald, J | 1 |
Adams, W; El-Bulbul, J; Goldberg, A; Jawahar, A; Joyce, C; Yacoub, J | 1 |
Anderson, SW; Babcock, KJ; Franz, ES; Goldstein, LE; Guermazi, A; Hua, N; Jara, H; Liu, X; Lupoli, N; Minaeva, O; Moncaster, JA; Soto, JA; Tripodis, Y | 1 |
Bano, E; Bicocchi, G; Bruno, E; Colombo Serra, S; Gaud, E; Tedoldi, F | 1 |
Froehlich, JM; Guirguis, N; Gutzeit, A; Koh, DM; Kolokythas, O; Matoori, S; Moussa, L; Sartoretti-Schefer, S; Wu, D | 1 |
Beets-Tan, RGH; Mann, RM; Schipper, RJ; Ter Beek, LC; van der Hoogt, KJJ; Wessels, R | 1 |
27 review(s) available for meglumine and gadolinium
Article | Year |
---|---|
Development of contrast media for magnetic resonance imaging.
Topics: Animals; Brain; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Safety; Spinal Cord | 1992 |
Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system.
Topics: Bone Diseases; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Joint Diseases; Magnetic Resonance Imaging; Meglumine; Muscular Diseases; Organometallic Compounds; Pentetic Acid; Soft Tissue Neoplasms; Spinal Diseases | 1991 |
Magnetic resonance imaging of the anal sphincter using an internal coil.
Topics: Anal Canal; Anus Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid | 1995 |
Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid; Safety | 1996 |
Radiologic-pathologic correlation: meningioma of the optic nerve sheath.
Topics: Contrast Media; Cranial Nerve Neoplasms; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Meningioma; Middle Aged; Optic Nerve Diseases; Organometallic Compounds; Pentetic Acid | 1996 |
MR imaging of cartilage: evaluation and comparison of MR imaging techniques.
Topics: Cartilage, Articular; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Reference Values | 1996 |
MR arthrography: a review of current technique and applications.
Topics: Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Joint Diseases; Joints; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid | 1997 |
Trends and developments in MRI contrast agent research.
Topics: Animals; Contrast Media; Gadolinium; Gated Blood-Pool Imaging; Humans; Image Enhancement; Liver; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 1997 |
[Current status of the clinical development of MR contrast media].
Topics: Adult; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections, Intravenous; Iron; Lymphography; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate; Suspensions | 1997 |
Gadobenate dimeglumine (Gd-BOPTA). An overview.
Topics: Animals; Central Nervous System Diseases; Contrast Media; Gadolinium; Heart Diseases; Humans; Liver Diseases; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds | 1998 |
Mechanisms of action of liver contrast agents: impact for clinical use.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Injections, Intravenous; Iron; Kupffer Cells; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate | 1999 |
Clinical utility and safety of MultiHance in magnetic resonance imaging of liver cancer: results of multicenter studies in Europe and the USA.
Topics: Carcinoma, Hepatocellular; Clinical Trials as Topic; Contrast Media; Europe; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Safety; United States | 1999 |
MultiHance: help or hype?
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 1999 |
Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium.
Topics: Animals; Chemistry, Pharmaceutical; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Mice; Organometallic Compounds | 1999 |
Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liver: mechanistic studies in animals.
Topics: Animals; Biological Transport; Contrast Media; Diagnosis, Differential; Disease Models, Animal; Gadolinium; Injections, Intravenous; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 1999 |
New contrast agents for imaging the liver.
Topics: Animals; Contrast Media; Edetic Acid; Ferric Compounds; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2001 |
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Meglumine; Organometallic Compounds; Pyridoxal Phosphate; Time Factors; Tomography, X-Ray Computed | 2004 |
Clinical experience with MultiHance in CNS imaging.
Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Randomized Controlled Trials as Topic; Sensitivity and Specificity | 2003 |
Contrast-enhanced cardiac MR imaging.
Topics: Contrast Media; Coronary Circulation; Gadolinium; Heart Neoplasms; Humans; Magnetic Resonance Imaging, Cine; Meglumine; Myocardial Ischemia; Organometallic Compounds | 2003 |
Gadobenate dimeglumine (MultiHance) for magnetic resonance angiography: review of the literature.
Topics: Carotid Stenosis; Contrast Media; Gadolinium; Humans; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds; Peripheral Vascular Diseases; Pulmonary Artery; Sensitivity and Specificity | 2003 |
New MR techniques for the detection of liver metastases.
Topics: Adenocarcinoma; Artifacts; Colorectal Neoplasms; Contrast Media; Cysts; Equipment Design; Fatty Liver; Forecasting; Gadolinium; Gadolinium DTPA; Humans; Imaging, Three-Dimensional; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2006 |
Gadolinium-Induced Fibrosis.
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Terminology as Topic | 2016 |
Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Meglumine; Metabolic Clearance Rate; Mice; Models, Animal; Organometallic Compounds; Rats; Reference Values; Tissue Distribution | 2016 |
Critical Questions Regarding Gadolinium Deposition in the Brain and Body After Injections of the Gadolinium-Based Contrast Agents, Safety, and Clinical Recommendations in Consideration of the EMA's Pharmacovigilance and Risk Assessment Committee Recommend
Topics: Animals; Bone and Bones; Brain; Contrast Media; Europe; Gadolinium; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Marketing; Meglumine; Muscle, Skeletal; Organometallic Compounds; Pharmacovigilance; Practice Guidelines as Topic; Risk Assessment | 2017 |
Distribution and chemical forms of gadolinium in the brain: a review.
Topics: Animals; Brain; Cerebellar Nuclei; Contrast Media; Environmental Pollutants; Gadolinium; Gadolinium DTPA; Globus Pallidus; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rats | 2017 |
Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis.
Topics: Contraindications, Drug; Contrast Media; Gadolinium; Glomerular Filtration Rate; Heterocyclic Compounds; Humans; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Risk; Severity of Illness Index; United States; United States Food and Drug Administration | 2020 |
Use of Real-Life Safety Data From International Pharmacovigilance Databases to Assess the Importance of Symptoms Associated With Gadolinium Exposure.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Meglumine; Organometallic Compounds; Pharmacovigilance; Quality of Life | 2022 |
44 trial(s) available for meglumine and gadolinium
Article | Year |
---|---|
Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
Topics: Adult; Aged; Aged, 80 and over; Brain Diseases; Brain Neoplasms; Contrast Media; Double-Blind Method; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1992 |
Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Retrospective Studies; Single-Blind Method; Spleen; Splenic Diseases; Tomography, X-Ray Computed | 1992 |
[NMR tomography of the liver with the new contrast agent Gd-BOPTA. The results of an in-vivo phase-I test].
Topics: Acetates; Contrast Media; Dose-Response Relationship, Drug; Drug Evaluation; Gadolinium; Gallbladder; Humans; Kidney; Liver; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Spleen; Time Factors | 1992 |
Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure.
Topics: Adult; Aged; Clinical Trials as Topic; Contrast Media; Drug Combinations; Drug Tolerance; Female; Gadolinium; Gadolinium DTPA; Humans; Kidney; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Time Factors | 1992 |
Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
Topics: Carcinoma, Renal Cell; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Kidney; Kidney Diseases, Cystic; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity | 1991 |
MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol.
Topics: Adult; Agar; Aged; Brain Neoplasms; Contrast Media; Drug Combinations; Drug Evaluation; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Models, Structural; Organometallic Compounds; Pentetic Acid; Single-Blind Method | 1991 |
Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
Topics: Bilirubin; Clinical Trials as Topic; Contrast Media; Drug Combinations; Electrocardiography; Electroencephalography; Gadolinium; Gadolinium DTPA; Headache; Humans; Iron; Magnetic Resonance Imaging; Meglumine; Nausea; Organometallic Compounds; Paresthesia; Pentetic Acid; Research Design; Sorbitol; United States | 1990 |
Gadopentetate dimeglumine: observations on the clinical research process.
Topics: Clinical Trials as Topic; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Research Design; Sorbitol; United States; United States Food and Drug Administration | 1990 |
Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.
Topics: Adult; Aged; Central Nervous System; Central Nervous System Diseases; Chi-Square Distribution; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1995 |
Gadopentetate dimeglumine-enhanced MR of the brain: clinical utility and safety in patients younger than two years of age.
Topics: Brain Diseases; Child, Preschool; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1994 |
Detection of pituitary microadenomas: comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging.
Topics: Adenoma; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Prolactinoma | 1994 |
MR imaging of pituitary region lesions with gadodiamide injection.
Topics: Adenoma; Adult; Aged; Contrast Media; Craniopharyngioma; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Diseases; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 1994 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid | 1993 |
MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications.
Topics: Adolescent; Central Nervous System Diseases; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid; Randomized Controlled Trials as Topic; Safety | 1996 |
Myometrial invasion of endometrial carcinoma: assessment with dynamic MR and contrast-enhanced T1-weighted images.
Topics: Adult; Aged; Contrast Media; Diagnostic Errors; Drug Combinations; Endometrial Neoplasms; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Menopause; Middle Aged; Myometrium; Neoplasm Invasiveness; Organometallic Compounds; Pentetic Acid; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity | 1997 |
Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation.
Topics: Carcinoma, Hepatocellular; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Time Factors | 1997 |
Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA).
Topics: Aged; Carcinoma, Hepatocellular; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds | 1999 |
Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Insufficiency; Safety; Spectrophotometry, Atomic | 1999 |
MultiHance in the assessment of intracranial tumors: results of phase II clinical studies.
Topics: Adult; Aged; Brain; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Echo-Planar Imaging; Female; Gadolinium; Humans; Injections, Intravenous; Male; Meglumine; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Pilot Projects; Reproducibility of Results; Safety | 1999 |
MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment.
Topics: Adenoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Focal Nodular Hyperplasia; Gadolinium; Hemangioma; Humans; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Prospective Studies | 1999 |
Clinical late phase II trials of MultiHance (Gd-BOPTA) for the magnetic resonance imaging of liver tumors in Japan.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Humans; Japan; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Safety | 1999 |
Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Europe; Female; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Sensitivity and Specificity | 2000 |
Gadolinium-based contrast: an alternative contrast agent for endovascular interventions.
Topics: Angiography; Contrast Media; Female; Gadolinium; Humans; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Vascular Surgical Procedures | 2000 |
Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency.
Topics: Contrast Media; Double-Blind Method; Gadolinium; Humans; Infusions, Intravenous; Meglumine; Organometallic Compounds; Renal Insufficiency | 2000 |
Off-site evaluation of liver lesion detection by Gd-BOPTA-enhanced MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Echo-Planar Imaging; Female; Gadolinium; Humans; Injections, Intravenous; Liver Neoplasms; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Prospective Studies; Reproducibility of Results; Tomography, X-Ray Computed | 2001 |
A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (Gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology.
Topics: Brain Neoplasms; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2001 |
Detection of intracranial metastases: a multicenter, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dosage.
Topics: Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2001 |
Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2001 |
Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine.
Topics: Brain Neoplasms; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Safety | 2002 |
Pharmacokinetics and safety of gadobenate dimeglumine (multihance) in subjects with impaired liver function.
Topics: Adult; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Liver; Liver Diseases; Male; Meglumine; Middle Aged; Organometallic Compounds | 2002 |
Gadobenate dimeglumine-enhanced MR angiography of the abdominal aorta and renal arteries.
Topics: Adult; Aged; Aorta, Abdominal; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Imaging, Three-Dimensional; Injections, Intravenous; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Artery | 2002 |
Gadobenate dimeglumine-enhanced magnetic resonance angiography of the pelvic arteries.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aorta, Abdominal; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Proteinuria; Renal Artery | 2003 |
[Contrast-enhanced MR angiography (CEMRA) in peripheral arterial occlusive disease (PAOD): conventional moving table technique versus hybrid technique].
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Contrast Media; Diabetes Mellitus, Type 2; Female; Gadolinium; Humans; Image Enhancement; Imaging, Three-Dimensional; Leg; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Peripheral Vascular Diseases | 2004 |
Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Double-Blind Method; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Infant; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Prospective Studies; Safety; Spinal Neoplasms | 2005 |
Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Peripheral Arterial Disease; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2011 |
Dynamic susceptibility contrast perfusion MRI identifies persistent vessel pathology in acute pontine stroke.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain Damage, Chronic; Cerebral Arteries; Cerebrovascular Circulation; Contrast Media; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Gadolinium; Humans; Infarction, Posterior Cerebral Artery; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Perfusion Imaging; Pons; Severity of Illness Index | 2010 |
Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Cross-Over Studies; Europe; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Artery; Renal Artery Obstruction; Reproducibility of Results; Sensitivity and Specificity | 2010 |
3.0-T whole-heart coronary magnetic resonance angiography: comparison of gadobenate dimeglumine and gadofosveset trisodium.
Topics: Adult; Contrast Media; Coronary Vessels; Female; Gadolinium; Healthy Volunteers; Humans; Magnetic Resonance Angiography; Male; Maryland; Meglumine; Observer Variation; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Signal-To-Noise Ratio; Young Adult | 2013 |
Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T in patients with chronic myocardial infarction using Gd-BOPTA.
Topics: Aged; Aged, 80 and over; Chronic Disease; Contrast Media; Dose-Response Relationship, Drug; Electrocardiography; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardial Infarction; Myocardium; Organometallic Compounds; ROC Curve; Severity of Illness Index | 2014 |
Comparison of gadofosveset (Vasovist(®)) with gadobenate dimeglumine (Multihance(®))-enhanced MR angiography for high-grade carotid artery stenosis.
Topics: Adult; Aged; Aged, 80 and over; Carotid Stenosis; Cerebral Angiography; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity | 2015 |
A comparison between gadofosveset trisodium and gadobenate dimeglumine for steady state MRA of the thoracic vasculature.
Topics: Adult; Contrast Media; Gadolinium; Heart; Humans; Magnetic Resonance Angiography; Meglumine; Middle Aged; Organometallic Compounds; Radiography | 2014 |
A Pharmacokinetics, Efficacy, and Safety Study of Gadoterate Meglumine in Pediatric Subjects Aged Younger Than 2 Years.
Topics: Brain; Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Humans; Image Enhancement; Infant; Infant, Newborn; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Prospective Studies; Spine | 2018 |
Effects of gadolinium-based magnetic resonance imaging contrast media on red blood cells and K562 cancer cells.
Topics: Contrast Media; Erythrocytes; Gadolinium; Humans; K562 Cells; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2020 |
Editorial for "Does the Higher Relaxivity of Gadobenate Dimeglumine Permit Gadolinium Dose-Lowering in MRI of the Central Nervous System? Results of a Retrospective, Parallel Group Comparison".
Topics: Central Nervous System; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies | 2021 |
420 other study(ies) available for meglumine and gadolinium
Article | Year |
---|---|
Iron-dextran as a magnetic susceptibility contrast agent: flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain.
Topics: Acetazolamide; Animals; Brain; Capillaries; Cats; Cerebrovascular Circulation; Contrast Media; Dextrans; Electron Spin Resonance Spectroscopy; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Image Enhancement; Iron; Iron-Dextran Complex; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Organometallic Compounds; Oxides; Pentetic Acid; Rats; Rats, Inbred Strains; Rheology | 1992 |
Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Soft Tissue Neoplasms | 1992 |
Intracranial lesion enhancement with gadolinium: T1-weighted spin-echo versus three-dimensional Fourier transform gradient-echo MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Brain Diseases; Brain Ischemia; Brain Neoplasms; Cerebrovascular Disorders; Contrast Media; Drug Combinations; Encephalitis; Female; Fourier Analysis; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1992 |
Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Contrast Media; Doxorubicin; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Methotrexate; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Remission Induction; Subtraction Technique | 1992 |
MR imaging of clival and paraclival lesions.
Topics: Adult; Child; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Skull; Skull Neoplasms; Tomography, X-Ray Computed | 1992 |
Miliary tuberculosis involving the brain: MR findings.
Topics: Brain; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Infant; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Tuberculosis, Meningeal; Tuberculosis, Miliary | 1992 |
Evaluation of experimental early acute cerebral ischemia before the development of edema: use of dynamic, contrast-enhanced and diffusion-weighted MR scanning.
Topics: Acute Disease; Animals; Brain Edema; Brain Ischemia; Contrast Media; Dextrans; Drug Combinations; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pentetic Acid; Polylysine; Rats; Rats, Inbred SHR; Time Factors | 1992 |
Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Pentetic Acid; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 1992 |
Gadolinium-enhanced MR imaging of renal masses.
Topics: Carcinoma, Renal Cell; Contrast Media; Cysts; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Kidney Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid | 1992 |
Fat-suppression MR arthrography of the shoulder.
Topics: Adipose Tissue; Contrast Media; Diagnosis, Differential; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Rotator Cuff; Rotator Cuff Injuries; Shoulder Joint | 1992 |
Osteomyelitis in children: gadolinium-enhanced MR imaging.
Topics: Abscess; Child; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Osteomyelitis; Pentetic Acid; Staphylococcal Infections | 1992 |
Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Contrast Media; Drug Combinations; Endometrial Neoplasms; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Middle Aged; Myometrium; Organometallic Compounds; Pentetic Acid; Uterine Cervical Neoplasms; Uterine Diseases; Uterine Neoplasms; Uterus | 1992 |
MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images.
Topics: Contrast Media; Drug Combinations; Endometrial Neoplasms; Endometriosis; Female; Gadolinium; Gadolinium DTPA; Humans; Leiomyoma; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Polyps; Sensitivity and Specificity; Uterine Neoplasms | 1992 |
Inadvertent i.v. administration of gadopentetate dimeglumine during early pregnancy.
Topics: Adult; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Pregnancy | 1992 |
Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging.
Topics: Adult; Contrast Media; Demyelinating Diseases; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Optic Nerve Diseases; Optic Neuritis; Orbit; Organometallic Compounds; Pentetic Acid; Visual Acuity | 1992 |
Intraorbital optic nerve and experimental optic neuritis. Correlation of fat suppression magnetic resonance imaging and electron microscopy.
Topics: Adipose Tissue; Animals; Contrast Media; Drug Combinations; Encephalomyelitis, Autoimmune, Experimental; Gadolinium; Gadolinium DTPA; Guinea Pigs; Magnetic Resonance Imaging; Meglumine; Optic Nerve; Optic Neuritis; Orbit; Organometallic Compounds; Pentetic Acid | 1992 |
Amelioration of cardiodepressive effects of gadopentetate dimeglumine with addition of ionic calcium.
Topics: Animals; Calcium; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heart; Hemodynamics; In Vitro Techniques; Ions; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1992 |
Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Topics: Acetates; Animals; Bile; Contrast Media; Duodenum; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Gallbladder; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Mice; Models, Statistical; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Time Factors | 1992 |
Magnetic resonance imaging contrast agents.
Topics: Abdomen; Animals; Brain Diseases; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Spinal Diseases | 1992 |
Gadopentetate dimeglumine as a marker of renal function. Magnetic resonance imaging to glomerular filtration rates.
Topics: Animals; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Rabbits; Radionuclide Imaging; Technetium Tc 99m Pentetate; Time Factors; Urologic Diseases | 1991 |
Gd-BOPTA/Dimeg: experimental disease imaging.
Topics: Acetates; Animals; Contrast Media; Coronary Disease; Gadolinium; Gadolinium DTPA; Liver Neoplasms, Experimental; Meglumine; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1991 |
Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Contrast Media; Drug Combinations; Evaluation Studies as Topic; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Uterine Cervical Neoplasms; Uterine Neoplasms; Uterus | 1991 |
Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Ovarian Diseases; Ovarian Neoplasms; Ovary; Pentetic Acid | 1991 |
Diagnosis of pancreatic transplant dysfunction: value of gadopentetate dimeglumine-enhanced MR imaging.
Topics: Adult; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Graft Rejection; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pancreas Transplantation; Pancreatic Function Tests; Pentetic Acid; Time Factors | 1991 |
MR imaging of CSF-like choroidal fissure and parenchymal cysts of the brain.
Topics: Adolescent; Adult; Aged; Brain Diseases; Cerebral Ventricles; Child; Child, Preschool; Cysts; Drug Combinations; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Temporal Lobe; Tomography, X-Ray Computed | 1990 |
Spinal cord pial metastases: MR imaging with gadopentetate dimeglumine.
Topics: Adult; Aged; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Meningeal Neoplasms; Middle Aged; Organometallic Compounds; Pentetic Acid; Pia Mater; Spinal Cord Neoplasms | 1990 |
MR imaging of the normal and abnormal clivus.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Contrast Media; Cranial Fossa, Posterior; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Retrospective Studies; Skull Neoplasms | 1990 |
Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images.
Topics: Adult; Brain Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Sarcoidosis | 1990 |
MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction.
Topics: Animals; Cholestasis; Chromium; Contrast Media; Edetic Acid; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Male; Manganese; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Rats, Inbred Strains | 1990 |
Persistent and recurrent hyperparathyroidism: assessment with gadopentetate dimeglumine-enhanced MR imaging.
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Hyperparathyroidism; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Muscles; Organometallic Compounds; Parathyroid Glands; Pentetic Acid; Prospective Studies; Recurrence; Thyroid Gland | 1990 |
Tolerance of extracellular contrast agents for magnetic resonance imaging.
Topics: Animals; Contrast Media; Drug Combinations; Drug Tolerance; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Meglumine; Mice; Organometallic Compounds; Osmolar Concentration; Pentetic Acid; Rats | 1990 |
The effect of intra-articular gadolinium-DTPA on synovial membrane and cartilage.
Topics: Animals; Cartilage, Articular; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Injections, Intra-Articular; Knee Joint; Meglumine; Organometallic Compounds; Pentetic Acid; Rabbits; Sorbitol; Synovial Membrane | 1990 |
Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver.
Topics: Acetates; Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1990 |
[A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
Topics: Acetates; Animals; Contrast Media; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gadolinium; Gadolinium DTPA; Lethal Dose 50; Liver; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Meglumine; Organometallic Compounds; Pentetic Acid; Rats | 1990 |
Contrast-enhanced MRI of tumors. Comparison of Gd-DTPA and a macromolecular agent.
Topics: Albumins; Animals; Drug Combinations; Female; Fibrosarcoma; Gadolinium; Gadolinium DTPA; Image Enhancement; Macromolecular Substances; Magnetic Resonance Imaging; Meglumine; Mice; Mice, Inbred BALB C; Organometallic Compounds; Pentetic Acid | 1989 |
[Gadolinium dimeglumine gadopentetate compared to CPMG sequencing and image synthesis].
Topics: Brain Diseases; Brain Neoplasms; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Sorbitol | 1988 |
Spinal lesions: quantitative and qualitative temporal evolution of gadopentetate dimeglumine enhancement in MR imaging.
Topics: Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Sorbitol; Spinal Cord Diseases; Spinal Cord Neoplasms; Spinal Diseases; Spinal Neoplasms; Time Factors | 1989 |
The measurement of extracellular water volumes in tissues by gadolinium modification of 1H-NMR spin lattice (T1) relaxation.
Topics: Animals; Chromium Radioisotopes; Contrast Media; Edetic Acid; Extracellular Space; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Mice; Neoplasms, Experimental; Organometallic Compounds; Pentetic Acid | 1986 |
B-19036, a potential new hepatobiliary contrast agent for MR proton imaging.
Topics: Acetates; Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Meglumine; Mice; Organometallic Compounds; Pentetic Acid; Rats; Tissue Distribution | 1988 |
Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Brain; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Spectroscopy; Meglumine; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Sorbitol; Tomography, X-Ray Computed | 1987 |
1H-NMR relaxation times and water compartmentalization in experimental tumor models.
Topics: Animals; Body Fluid Compartments; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Mice; Neoplasms, Experimental; Organometallic Compounds; Pentetic Acid | 1986 |
Cerebrospinal fluid rhinorrhea: depiction with MR cisternography in dogs.
Topics: Animals; Cerebrospinal Fluid Rhinorrhea; Dogs; Female; Gadolinium; Magnetic Resonance Spectroscopy; Meglumine; Pentetic Acid | 1986 |
First use of GdDTPA/dimeglumine in man.
Topics: Adult; Contrast Media; Drug Evaluation; Gadolinium; Humans; Kidney; Magnetic Resonance Spectroscopy; Male; Meglumine; Pentetic Acid; Sorbitol; Urinary Bladder | 1984 |
Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.
Topics: Contrast Media; Drug Evaluation; Gadolinium; Humans; Injections, Intravenous; Kidney; Kinetics; Magnetic Resonance Spectroscopy; Meglumine; Metabolic Clearance Rate; Pentetic Acid; Sorbitol | 1984 |
Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Carcinoma; Carcinoma in Situ; Carcinoma, Ductal, Breast; Contrast Media; Drug Combinations; Female; Fibroadenoma; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Lymph Nodes; Magnetic Resonance Imaging; Mammography; Meglumine; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Organometallic Compounds; Pentetic Acid; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone | 1995 |
Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging.
Topics: Adenoma; Adipose Tissue; Adrenal Gland Neoplasms; Adult; Aged; Carcinoma; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Lipids; Liver; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Muscle, Skeletal; Organometallic Compounds; Pentetic Acid; Pheochromocytoma; Prospective Studies; Sensitivity and Specificity; Signal Processing, Computer-Assisted | 1995 |
Femoral head perfusion and composition: MR imaging and spectroscopic evaluation of patients with systemic lupus erythematosus and at risk for avascular necrosis.
Topics: Adipose Tissue; Adolescent; Adult; Bone Marrow; Case-Control Studies; Contrast Media; Drug Combinations; Female; Femur Head; Femur Neck; Gadolinium; Gadolinium DTPA; Hip Joint; Humans; Image Enhancement; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Meglumine; Middle Aged; Organometallic Compounds; Osteonecrosis; Pentetic Acid; Prednisone; Regional Blood Flow; Risk Factors | 1995 |
Spinal cord ependymomas: MR imaging features.
Topics: Adolescent; Adult; Aged; Child; Contrast Media; Cysts; Drug Combinations; Ependymoma; Female; Gadolinium; Gadolinium DTPA; Hemosiderin; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Retrospective Studies; Spinal Cord; Spinal Cord Neoplasms | 1995 |
Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Mammography; Mastectomy; Meglumine; Middle Aged; Neoplasm Invasiveness; Organometallic Compounds; Pentetic Acid; Preoperative Care; Sensitivity and Specificity; Ultrasonography, Mammary | 1995 |
Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Abdominal; Aortography; Arterial Occlusive Diseases; Celiac Artery; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Infusions, Intravenous; Magnetic Resonance Angiography; Male; Meglumine; Mesenteric Artery, Superior; Middle Aged; Organometallic Compounds; Pentetic Acid; Renal Artery; Renal Artery Obstruction; Respiration; Signal Processing, Computer-Assisted; Time Factors | 1995 |
Anterior shoulder instability: diagnostic criteria determined from prospective analysis of 121 MR arthrograms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthroscopy; Cartilage, Articular; Contrast Media; Diagnostic Techniques, Surgical; Drug Combinations; Female; Forecasting; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Joint Instability; Ligaments, Articular; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Rupture; Sensitivity and Specificity; Shoulder Injuries; Shoulder Joint | 1995 |
Musculoskeletal neoplasm: perineoplastic edema versus tumor on dynamic postcontrast MR images with spatial mapping of instantaneous enhancement rates.
Topics: Adolescent; Adult; Biopsy; Bone Neoplasms; Child; Contrast Media; Drug Combinations; Edema; Female; Forecasting; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Logistic Models; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Muscular Diseases; Neoplasm Invasiveness; Organometallic Compounds; Patient Care Planning; Pentetic Acid | 1995 |
Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
Topics: Adult; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Radionuclide Imaging; Reference Values; Renal Artery Obstruction; Technetium Tc 99m Pentetate | 1995 |
Is it necessary to routinely use gadolinium in the MR imaging evaluation of soft-tissue tumors of the extremities?
Topics: Contrast Media; Drug Combinations; Extremities; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Soft Tissue Neoplasms | 1995 |
Clinical safety of gadopentetate dimeglumine.
Topics: Asthma; Cohort Studies; Contrast Media; Drug Combinations; Drug Hypersensitivity; Female; Gadolinium; Gadolinium DTPA; Humans; Hypersensitivity; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Product Surveillance, Postmarketing; Prospective Studies; Time Factors | 1995 |
Fast MR angiography of the aortoiliac arteries and arteries of the lower extremity: value of bolus-enhanced, whole-volume subtraction technique.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Dissection; Contrast Media; Female; Gadolinium; Humans; Iliac Artery; Leg; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Reference Values; Subtraction Technique | 1995 |
Eye and testicular pain after administration of gadopentetate dimeglumine.
Topics: Contrast Media; Drug Combinations; Eye; Gadolinium; Gadolinium DTPA; Humans; Male; Meglumine; Middle Aged; Organometallic Compounds; Pain; Pentetic Acid; Testis; Time Factors | 1995 |
Plantar compartments of the foot: MR appearance in cadavers and diabetic patients.
Topics: Cadaver; Contrast Media; Copper; Copper Sulfate; Diabetic Foot; Drug Combinations; Exudates and Transudates; Fascia; Foot; Gadolinium; Gadolinium DTPA; Gelatin; Humans; Iothalamate Meglumine; Magnetic Resonance Imaging; Meglumine; Metatarsophalangeal Joint; Metatarsus; Methylene Blue; Muscle, Skeletal; Organometallic Compounds; Pentetic Acid; Soft Tissue Infections; Tendons | 1995 |
Dynamic contrast-enhanced subtraction MR angiography of the lower extremities: initial evaluation with a multisection two-dimensional time-of-flight sequence.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Arterial Occlusive Diseases; Arteries; Constriction, Pathologic; Contrast Media; Drug Combinations; Echo-Planar Imaging; Evaluation Studies as Topic; Feasibility Studies; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Leg; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Models, Structural; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity; Subtraction Technique | 1995 |
Vascular complications of pancreatic transplantation: MR evaluation.
Topics: Adult; Chronic Disease; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Graft Occlusion, Vascular; Graft Rejection; Humans; Image Enhancement; Infarction; Kidney Transplantation; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreas; Pancreas Transplantation; Pentetic Acid; Regional Blood Flow; Thrombosis; Vascular Diseases; Vascular Patency | 1995 |
Gadopentetate-dimeglumine-enhanced MR imaging of osteonecrosis and osteochondritis dissecans of the elbow: initial experience.
Topics: Adolescent; Adult; Bone Marrow; Child; Contrast Media; Drug Combinations; Elbow Joint; Female; Gadolinium; Gadolinium DTPA; Humans; Humerus; Image Enhancement; Joint Diseases; Joint Loose Bodies; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Osteochondritis Dissecans; Osteonecrosis; Pentetic Acid; Radiography; Radius | 1995 |
Vacuum phenomena in insufficiency fractures of the sacrum.
Topics: Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Follow-Up Studies; Fractures, Spontaneous; Gadolinium; Gadolinium DTPA; Gases; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Radiographic Image Enhancement; Radionuclide Imaging; Retrospective Studies; Sacroiliac Joint; Sacrum; Spinal Fractures; Spinal Neoplasms; Tomography, X-Ray Computed; Vacuum | 1995 |
Magnetic resonance arthrography of the scapulohumeral joint in dogs, using gadopentetate dimeglumine.
Topics: Animals; Arthrography; Contrast Media; Dog Diseases; Dogs; Drug Combinations; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Osteochondritis; Pentetic Acid; Shoulder Joint | 1995 |
ADH-evoked [Cl-]i-dependent transient in whole cell current of distal nephron cell line A6.
Topics: Animals; Barium; Cattle; Cell Line; Chlorides; Gadolinium; Meglumine; Membrane Potentials; Nephrons; Patch-Clamp Techniques; Time Factors; Vasopressins; Vasotocin | 1995 |
The striated cerebellum: an MR imaging sign in Lhermitte-Duclos disease (dysplastic gangliocytoma).
Topics: Adult; Cerebellar Neoplasms; Cerebellum; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Ganglioneuroma; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Retrospective Studies | 1995 |
Enhancement of intervertebral disks with gadolinium complexes: comparison of an ionic and a nonionic medium in an animal model.
Topics: Animals; Contrast Media; Diffusion; Disease Models, Animal; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Infusions, Intravenous; Intervertebral Disc; Lumbar Vertebrae; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Rabbits | 1994 |
MR imaging of spondylitis with gadopentetate dimeglumine enhancement.
Topics: Adult; Aged; Bone Marrow; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Infant; Intervertebral Disc; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Mycoses; Organometallic Compounds; Pentetic Acid; Postoperative Complications; Retrospective Studies; Spondylitis; Tuberculosis, Spinal | 1994 |
Lymphocytic adenohypophysitis: contrast-enhanced MR imaging in five cases.
Topics: Adenoma; Adolescent; Adult; Autoimmune Diseases; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Lymphocytes; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Pituitary Diseases; Pituitary Gland, Anterior; Pituitary Neoplasms; Retrospective Studies | 1995 |
Correlation between Gd-enhanced MR imaging and histopathology in treated and untreated 9L rat brain tumors.
Topics: Animals; Brain Neoplasms; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Neoplasm Transplantation; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 1995 |
Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up.
Topics: Acute Disease; Adolescent; Adult; Aged; Brain; Contrast Media; Diagnosis, Differential; Drug Combinations; Encephalomyelitis; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Myelitis; Organometallic Compounds; Pentetic Acid; Spinal Cord; Spinal Cord Diseases | 1995 |
Early MR detection of experimentally induced cerebral ischemia using magnetic susceptibility contrast agents: comparison between gadopentetate dimeglumine and iron oxide particles.
Topics: Animals; Blood Volume; Brain Ischemia; Capillary Permeability; Cerebral Angiography; Cerebrovascular Circulation; Contrast Media; Disease Models, Animal; Drug Combinations; Ferric Compounds; Gadolinium; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Magnetics; Male; Meglumine; Microcirculation; Microradiography; Organometallic Compounds; Pentetic Acid; Rats; Rats, Wistar | 1995 |
Craniopharyngiomas--the utility of contrast medium enhancement for MR imaging at 1.5 T.
Topics: Adolescent; Adult; Child; Child, Preschool; Contrast Media; Craniopharyngioma; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Optic Chiasm; Organometallic Compounds; Pentetic Acid; Pituitary Neoplasms | 1994 |
Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging.
Topics: Brain; Cerebrovascular Circulation; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Indicator Dilution Techniques; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Tomography, Emission-Computed | 1994 |
Utility of high-dose contrast enhancement for detecting recurrent herniated intervertebral disks.
Topics: Animals; Cicatrix; Contrast Media; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Combinations; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Intervertebral Disc Displacement; Laminectomy; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Postoperative Complications; Recurrence | 1994 |
Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
Topics: Adolescent; Adult; Aged; Artifacts; Brain; Brain Neoplasms; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Glioma; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Meningioma; Middle Aged; Neurilemmoma; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1994 |
Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine.
Topics: Adolescent; Adult; Arachnoid; Bone Neoplasms; Brain; Brain Neoplasms; Cerebral Ventricles; Child; Child, Preschool; Contrast Media; Drug Combinations; Dura Mater; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Infant; Magnetic Resonance Imaging; Male; Medulloblastoma; Meglumine; Neoplasm Recurrence, Local; Organometallic Compounds; Pentetic Acid; Pia Mater; Postoperative Care; Retrospective Studies | 1994 |
Germinoma originating in the basal ganglia and thalamus: MR and CT evaluation.
Topics: Adolescent; Atrophy; Basal Ganglia Diseases; Brain; Brain Neoplasms; Brain Stem; Calcinosis; Child; Contrast Media; Cysts; Drug Combinations; Gadolinium; Gadolinium DTPA; Germinoma; Hemorrhage; Humans; Image Enhancement; Iodine; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Radiographic Image Enhancement; Retrospective Studies; Thalamic Diseases; Tomography, X-Ray Computed | 1994 |
Venous congestion: an MR finding in dural arteriovenous malformations with cortical venous drainage.
Topics: Adult; Aged; Brain Edema; Cerebellar Diseases; Cerebral Angiography; Cerebral Hemorrhage; Cerebral Veins; Cerebrovascular Circulation; Constriction, Pathologic; Contrast Media; Dilatation, Pathologic; Drug Combinations; Dura Mater; Female; Gadolinium; Gadolinium DTPA; Humans; Hydrocephalus; Intracranial Arteriovenous Malformations; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pia Mater; Retrospective Studies; Subarachnoid Hemorrhage | 1994 |
MR of corticotropin-secreting pituitary microadenomas.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Contrast Media; Cushing Syndrome; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Retrospective Studies; Sensitivity and Specificity | 1994 |
MR assessment of radiation-induced blood-brain barrier permeability changes in rat glioma model.
Topics: Animals; Astrocytoma; Blood-Brain Barrier; Brain; Brain Neoplasms; Capillary Permeability; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Image Enhancement; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Permeability; Radiotherapy Dosage; Radiotherapy, High-Energy; Rats; Rats, Inbred F344; Tissue Distribution; Tumor Cells, Cultured | 1994 |
Frequency of unexplained meningeal enhancement in the brain after lumbar puncture.
Topics: Adult; Aged; Aged, 80 and over; Arachnoid; Cell Count; Cerebrospinal Fluid; Contrast Media; Drug Combinations; Dura Mater; Erythrocytes; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Retrospective Studies; Spinal Puncture | 1994 |
Gadolinium enhancement of the leptomeninges caused by hydrocephalus: a potential mimic of leptomeningeal metastasis.
Topics: Adult; Arachnoid; Astrocytoma; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Drug Combinations; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Hydrocephalus; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Meningeal Neoplasms; Organometallic Compounds; Pentetic Acid; Pia Mater | 1994 |
Orbital and optic pathway sarcoidosis: MR findings.
Topics: Adolescent; Adult; Cavernous Sinus; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Lacrimal Apparatus Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Ophthalmoplegia; Optic Atrophy; Optic Chiasm; Optic Nerve Diseases; Orbital Diseases; Organometallic Compounds; Pentetic Acid; Retrospective Studies; Sarcoidosis | 1994 |
Magnetic resonance imaging findings in Vogt-Koyanagi-Harada syndrome.
Topics: Adult; Aged; Brain; Child; Choroid; Contrast Media; Drug Combinations; Female; Fluorescein Angiography; Fundus Oculi; Gadolinium; Gadolinium DTPA; Humans; Hypertrophy; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Retinal Detachment; Tomography, X-Ray Computed; Uveomeningoencephalitic Syndrome | 1994 |
The uterine cervix on in vitro and in vivo MR images: a study of zonal anatomy and vascularity using an enveloping cervical coil.
Topics: Adult; Cervix Uteri; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Parity; Pentetic Acid; Reference Values | 1994 |
MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
Topics: Adult; Clinical Protocols; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Injections, Intra-Articular; Joint Instability; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Shoulder Joint; Time Factors; Triiodobenzoic Acids | 1994 |
Detection and staging of chondromalacia patellae: relative efficacies of conventional MR imaging, MR arthrography, and CT arthrography.
Topics: Adult; Cartilage Diseases; Cartilage, Articular; Contrast Media; Drug Combinations; False Positive Reactions; Female; Gadolinium; Gadolinium DTPA; Humans; Iohexol; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Patella; Pentetic Acid; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 1994 |
Cervical epidural spinal infection: MR imaging characteristics.
Topics: Cervical Vertebrae; Contrast Media; Discitis; Drug Combinations; Epidural Space; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Osteomyelitis; Pentetic Acid; Retrospective Studies; Staphylococcal Infections; Streptococcal Infections | 1994 |
Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
Topics: Carcinoma, Hepatocellular; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Radiography | 1994 |
MR imaging of the uterus: findings from high-resolution multisection dynamic imaging with a surface coil.
Topics: Adult; Aged; Artifacts; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Uterine Neoplasms; Uterus | 1994 |
Contrast-enhanced echo-planar MR imaging of myocardial perfusion: preliminary study in humans.
Topics: Adult; Artifacts; Contrast Media; Coronary Circulation; Coronary Disease; Drug Combinations; Echo-Planar Imaging; Female; Gadolinium; Gadolinium DTPA; Heart; Humans; Male; Meglumine; Organometallic Compounds; Pentetic Acid | 1994 |
Cerebral metastatic malignant melanoma: CT and MR findings with pathological correlation.
Topics: Aged; Aged, 80 and over; Brain Diseases; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Melanoma; Neoplasms, Unknown Primary; Organometallic Compounds; Pentetic Acid; Tomography, X-Ray Computed; Vasculitis | 1993 |
The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Child; Child, Preschool; Contrast Media; Drug Combinations; Evaluation Studies as Topic; Eye Neoplasms; Female; Gadolinium; Gadolinium DTPA; Humans; Infant; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Retinoblastoma; Uveal Neoplasms | 1994 |
Gadolinium-enhanced MR aortography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aorta; Aortic Aneurysm; Child; Child, Preschool; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Iliac Aneurysm; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity; Vena Cava, Inferior | 1994 |
Lesion enhancement in radio-frequency spoiled gradient-echo imaging: theory, experimental evaluation, and clinical implications.
Topics: Brain; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Magnetics; Meglumine; Models, Biological; Models, Structural; Organometallic Compounds; Pentetic Acid; Pilot Projects | 1994 |
Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
Topics: Adult; Anaphylaxis; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid | 1994 |
Histologic abnormalities associated with gadolinium enhancement on MR in the initial hours of experimental cerebral infarction.
Topics: Animals; Brain; Cerebral Infarction; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Necrosis; Organometallic Compounds; Papio; Pentetic Acid; Time Factors | 1994 |
Irradiation of the cervix uteri: value of unenhanced and contrast-enhanced MR imaging.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cervix Uteri; Contrast Media; Drug Combinations; Endometrium; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Lymph Nodes; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Organometallic Compounds; Pentetic Acid; Radiation Injuries; Radiotherapy Dosage; Retrospective Studies; Time Factors; Uterine Cervical Neoplasms | 1993 |
Diagnosis of low-grade chondrosarcoma.
Topics: Adult; Bone Neoplasms; Cartilage; Chondrosarcoma; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Radiography; Research Design | 1993 |
Cervical cancer: application of MR imaging in radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Brachytherapy; Contrast Media; Drug Combinations; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Organometallic Compounds; Patient Care Planning; Pelvic Bones; Pentetic Acid; Prospective Studies; Radiotherapy Dosage; Radiotherapy, High-Energy; Remission Induction; Sacrum; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 1993 |
Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications.
Topics: Buserelin; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Leiomyoma; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Uterine Neoplasms; Uterus | 1993 |
Dynamic MR imaging in the head and neck.
Topics: Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Predictive Value of Tests; Salivary Gland Neoplasms; Sensitivity and Specificity | 1993 |
Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hemangioma; Heterocyclic Compounds; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity | 1993 |
Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging.
Topics: Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Tomography, X-Ray Computed | 1993 |
Recurrent rectal cancer: diagnosis with dynamic MR imaging.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Pentetic Acid; Predictive Value of Tests; Rectal Neoplasms; Sensitivity and Specificity | 1993 |
Magnetic resonance imaging in a dog with choroid plexus carcinoma.
Topics: Animals; Choroid Plexus Neoplasms; Dog Diseases; Dogs; Drug Combinations; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Meglumine; Orchiectomy; Organometallic Compounds; Pentetic Acid | 1993 |
MR imaging of avascular necrosis and transient marrow edema of the femoral head.
Topics: Adult; Bone Diseases; Bone Marrow; Bone Marrow Diseases; Contrast Media; Edema; Epiphyses; Female; Femur Head; Femur Head Necrosis; Gadolinium; Hip Fractures; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 1993 |
Spinal epidural abscess: evaluation with gadolinium-enhanced MR imaging.
Topics: Abscess; Adolescent; Adult; Aged; Child; Child, Preschool; Contrast Media; Discitis; Drug Combinations; Epidural Space; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Infant; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Osteomyelitis; Pentetic Acid; Retrospective Studies; Spinal Cord; Spinal Diseases; Staphylococcal Infections; Suppuration | 1993 |
Hemodynamic effects of gadodiamide injection and gadopentetate dimeglumine in anesthetized dogs.
Topics: Anesthesia, Inhalation; Animals; Contrast Media; Dogs; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hemodynamics; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid | 1993 |
Design and preparation of ethyl cellulose microcapsules of gadopentetate dimeglumine for neutron-capture therapy using the Wurster process.
Topics: Cellulose; Drug Combinations; Drug Compounding; Gadolinium; Gadolinium DTPA; Meglumine; Neutron Capture Therapy; Organometallic Compounds; Particle Size; Pentetic Acid | 1993 |
Varied microcirculation of pituitary adenomas at rapid, dynamic, contrast-enhanced MR imaging.
Topics: Adenoma; Adult; Aged; Carotid Arteries; Cavernous Sinus; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Microcirculation; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Time Factors | 1993 |
Neuroimaging of juvenile pilocytic astrocytomas: an enigma.
Topics: Adolescent; Adult; Age Factors; Astrocytoma; Brain Neoplasms; Contrast Media; Deoxyglucose; Drug Combinations; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Glucose; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
Acute stroke in cats: comparison of dynamic susceptibility-contrast MR imaging with T2- and diffusion-weighted MR imaging.
Topics: Acute Disease; Animals; Blood Volume; Brain Ischemia; Cats; Cerebral Cortex; Cerebrovascular Circulation; Cerebrovascular Disorders; Contrast Media; Diffusion; Drug Combinations; Gadolinium; Gadolinium DTPA; Hemodynamics; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Time Factors | 1993 |
Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging.
Topics: Adolescent; Adult; Aged; Astrocytoma; Blood Volume; Brain Neoplasms; Cerebellar Neoplasms; Child; Contrast Media; Drug Combinations; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Glioma; Hemangiosarcoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Morton neuroma: evaluation with MR imaging performed with contrast enhancement and fat suppression.
Topics: Adipose Tissue; Adult; Aged; Contrast Media; Drug Combinations; Female; Foot Diseases; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Metatarsus; Middle Aged; Neuroma; Organometallic Compounds; Pentetic Acid | 1993 |
Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression.
Topics: Adenoma, Islet Cell; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Pentetic Acid; Prospective Studies; Retrospective Studies; Tomography, X-Ray Computed | 1993 |
Contrast-enhanced MR imaging of malignant mixed müllerian tumor of the uterus.
Topics: Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organometallic Compounds; Pentetic Acid; Uterine Neoplasms | 1993 |
Gadopentetate dimeglumine as an alternative contrast material for use in angiography.
Topics: Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Contrast Media; Drug Combinations; Embolization, Therapeutic; Gadolinium; Gadolinium DTPA; Hepatic Artery; Humans; Liver Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Rupture, Spontaneous | 1993 |
Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy.
Topics: Animals; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Infusions, Intra-Arterial; Male; Meglumine; Neoplasms, Experimental; Neutron Capture Therapy; Organometallic Compounds; Pentetic Acid; Rabbits | 1993 |
Evaluation of renal masses with contrast-enhanced rapid acquisition spin echo MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hamartoma; Humans; Kidney; Kidney Diseases, Cystic; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Pentetic Acid; ROC Curve; Time Factors; Tomography, X-Ray Computed | 1993 |
Aortic ghost artifact in ultrashort TE multislice gradient echo MR images is not increased by paramagnetic enhancement.
Topics: Aorta, Abdominal; Artifacts; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Models, Cardiovascular; Models, Structural; Organometallic Compounds; Pentetic Acid; Pulsatile Flow; Time Factors | 1993 |
Abdominal MR imaging: comparison of T2-weighted fast and conventional spin-echo, and contrast-enhanced fast multiplanar spoiled gradient-recalled imaging.
Topics: Abdomen; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings.
Topics: Adult; Aged; Bone Neoplasms; Cartilage; Chondrosarcoma; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Osteochondroma; Pentetic Acid; Sensitivity and Specificity | 1993 |
Severe adverse reaction to iv gadopentetate dimeglumine.
Topics: Adult; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Hypotension; Meglumine; Organometallic Compounds; Pentetic Acid; Tachycardia | 1993 |
Sequential analysis of infarcted and normal myocardium in piglets using in vivo gadolinium-enhanced MR images.
Topics: Animals; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heart Ventricles; Image Enhancement; Image Processing, Computer-Assisted; In Vitro Techniques; Magnetic Resonance Imaging; Male; Meglumine; Myocardial Infarction; Myocardium; Nitroblue Tetrazolium; Observer Variation; Organometallic Compounds; Pentetic Acid; Reproducibility of Results; Swine | 1993 |
Economic/reimbursement issues in MR imaging with gadolinium contrast agents.
Topics: Cost-Benefit Analysis; Costs and Cost Analysis; Drug Combinations; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Insurance, Health, Reimbursement; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Random Allocation; Sensitivity and Specificity; United States | 1993 |
Gadolinium magnetic resonance imaging dacryocystography.
Topics: Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Lacrimal Apparatus; Lacrimal Duct Obstruction; Magnetic Resonance Imaging; Meglumine; Nasolacrimal Duct; Ophthalmic Solutions; Organometallic Compounds; Pentetic Acid | 1993 |
Primary lymphoma of the liver: MR findings.
Topics: Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Efficacy of gadolinium administration in magnetic resonance imaging screening of patients with complex partial seizures and results of a normal neurologic examination.
Topics: Adult; Brain; Brain Neoplasms; Cerebellar Neoplasms; Contrast Media; Drug Combinations; Electroencephalography; Epilepsy, Complex Partial; Gadolinium; Gadolinium DTPA; Glioma; Hemangioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Meningeal Neoplasms; Meningioma; Neurologic Examination; Organometallic Compounds; Pentetic Acid; Prospective Studies; Temporal Lobe | 1995 |
Role of high-resolution magnetic resonance imaging for differentiating melanin-containing skin tumors.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Body Water; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Melanins; Melanoma; Middle Aged; Nevus, Blue; Nevus, Intradermal; Nevus, Pigmented; Organometallic Compounds; Pentetic Acid; Prospective Studies; Signal Processing, Computer-Assisted; Skin; Skin Neoplasms | 1995 |
Dosage of gadoteridol and adverse reactions relative to gadopentetate.
Topics: Contrast Media; Drug Combinations; Drug Labeling; Drug Utilization Review; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Hospitals; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Practice Guidelines as Topic; Retrospective Studies | 1995 |
Hemodynamic parameter assessment with dynamic susceptibility contrast magnetic resonance imaging in unilateral symptomatic internal carotid artery occlusion.
Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Blood Volume; Carotid Artery, Internal; Carotid Stenosis; Cerebrovascular Circulation; Cerebrovascular Disorders; Collateral Circulation; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Hemodynamics; Humans; Image Enhancement; Image Processing, Computer-Assisted; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1996 |
Diagnosis of renovascular hypertension: feasibility of captopril-sensitized dynamic MR imaging and comparison with captopril scintigraphy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Contrast Media; Feasibility Studies; Female; Gadolinium; Glomerular Filtration Rate; Humans; Hypertension, Renovascular; Kidney; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Radiography; Radionuclide Imaging; Renal Artery Obstruction; Technetium Tc 99m Mertiatide | 1996 |
Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Iopamidol; Kidney; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Pentetic Acid; Prospective Studies; Tomography, X-Ray Computed | 1996 |
Life-threatening anaphylactoid reaction after iv injection of gadoterate meglumine.
Topics: Adult; Anaphylaxis; Contrast Media; Female; Gadolinium; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 1996 |
Gadopentetate dimeglumine-enhanced MR imaging of subdural hematoma in an abused infant.
Topics: Child Abuse; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hematoma, Subdural; Humans; Infant; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Tomography, X-Ray Computed | 1996 |
Tarsometatarsal joint: anatomic details on MR images.
Topics: Cadaver; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; In Vitro Techniques; Ligaments, Articular; Magnetic Resonance Imaging; Meglumine; Metatarsal Bones; Metatarsophalangeal Joint; Organometallic Compounds; Pentetic Acid; Tarsal Joints | 1996 |
Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
Topics: Adult; Aged; Aneuploidy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Division; Contrast Media; DNA, Neoplasm; Drug Combinations; Female; Flow Cytometry; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Lymphatic Metastasis; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoplasm Invasiveness; Organometallic Compounds; Pentetic Acid; Prospective Studies; S Phase | 1996 |
Assessment of acute myocardial infarction in man with magnetic resonance imaging and the use of a new paramagnetic contrast agent gadolinium-BOPTA.
Topics: Adult; Aged; Contrast Media; Gadolinium; Heart; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Myocardial Infarction; Myocardium; Organometallic Compounds | 1996 |
Can gadolinium be safely given in renal failure?
Topics: Acute Kidney Injury; Contrast Media; Creatinine; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Kidney; Kidney Failure, Chronic; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid | 1996 |
[Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Topics: Anaphylaxis; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1996 |
Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients.
Topics: Colon; Colorectal Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fibrosis; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pelvic Neoplasms; Pentetic Acid; Predictive Value of Tests; Prospective Studies; Rectum; Sensitivity and Specificity; Subtraction Technique; Time Factors | 1996 |
[Infiltration patterns of plasmacytomas in magnetic resonance tomography].
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Bone Marrow Examination; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Myeloma; Organometallic Compounds; Pentetic Acid; Radiography; Spine | 1996 |
Contrast-enhanced dynamic magnetic resonance imaging of the rat kidney.
Topics: Angiotensin II; Animals; Contrast Media; Diuretics; Drug Combinations; Furosemide; Gadolinium; Gadolinium DTPA; Kidney; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Water | 1996 |
The use of gadolinium-BOPTA on magnetic resonance imaging in brain infection.
Topics: Animals; Brain; Brain Abscess; Contrast Media; Disease Models, Animal; Dogs; Enterococcus faecalis; Gadolinium; Gram-Positive Bacterial Infections; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 1996 |
Magnetization transfer or spin-lock? An investigation of off-resonance saturation pulse imaging with varying frequency offsets.
Topics: Adult; Agar; Brain; Brain Diseases; Brain Neoplasms; Cerebrovascular Disorders; Chlorides; Contrast Media; Corn Oil; Drug Combinations; Electron Spin Resonance Spectroscopy; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Macromolecular Substances; Magnetic Resonance Imaging; Male; Manganese Compounds; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Phantoms, Imaging; Water | 1996 |
Measurement of cerebral blood volume via the relaxing effect of low-dose gadopentetate dimeglumine during bolus transit.
Topics: Aged; Algorithms; Blood Flow Velocity; Blood Volume; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Contrast Media; Drug Combinations; Extracellular Space; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Meglumine; Meningeal Neoplasms; Meningioma; Models, Biological; Organometallic Compounds; Pentetic Acid; Phantoms, Imaging; Plasma Volume | 1996 |
Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.
Topics: Adult; Blood Volume; Brain; Brain Neoplasms; Cerebrovascular Circulation; Contrast Media; Drug Combinations; Echo-Planar Imaging; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Glioma; Humans; Image Enhancement; Injections, Intravenous; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Pentetic Acid; Tomography, Emission-Computed | 1996 |
Vascular MR contrast enhancement in cerebrovascular disease.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Ischemia; Carotid Artery, Internal; Carotid Stenosis; Cerebral Angiography; Cerebral Arteries; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascular Disorders; Collateral Circulation; Contrast Media; Drug Combinations; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1996 |
A choroid plexus papilloma arising from an incidental pineal cyst.
Topics: Adult; Brain Diseases; Cell Transformation, Neoplastic; Choroid Plexus Neoplasms; Contrast Media; Cysts; Disease Progression; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Papilloma; Pentetic Acid; Pineal Gland; Tomography, X-Ray Computed | 1996 |
Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
Topics: Adult; Aged; Breast; Breast Neoplasms; Breast Neoplasms, Male; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neovascularization, Pathologic; Organometallic Compounds; Pentetic Acid; Retrospective Studies | 1996 |
Laser therapy for breast cancer: MR imaging and histopathologic correlation.
Topics: Adult; Aged; Breast; Breast Neoplasms; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Laser Coagulation; Linear Models; Magnetic Resonance Imaging; Meglumine; Middle Aged; Necrosis; Organometallic Compounds; Pentetic Acid; Ultrasonography, Mammary | 1996 |
MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging.
Topics: Animals; Chelating Agents; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Half-Life; Haplorhini; Humans; Injections, Intravenous; Magnetic Resonance Angiography; Meglumine; Metabolic Clearance Rate; Organometallic Compounds; Pentetic Acid; Protein Binding; Rabbits; Rats; Serum Albumin; Species Specificity | 1996 |
Benign fibrous mesothelioma of the pleura: MR study and pathologic correlation.
Topics: Aged; Contrast Media; Drug Combinations; Female; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Mesothelioma; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Organometallic Compounds; Pentetic Acid; Pleural Neoplasms; Reproducibility of Results; Thorax; Vimentin | 1996 |
An experimental study on the neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Contrast Media; Drug Combinations; Evoked Potentials, Visual; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley | 1996 |
Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Retrospective Studies | 1996 |
Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Organometallic Compounds; Pentetic Acid; Prospective Studies; Rectum; Urinary Bladder; Uterine Cervical Neoplasms; Uterus; Vagina | 1996 |
Reverse enhancement of hemorrhagic brain lesions on postcontrast MR: detection with digital image subtraction.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Cerebral Hemorrhage; Child; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Methemoglobin; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity; Software; Subtraction Technique | 1996 |
3D gadolinium-enhanced MR angiography of the carotid arteries.
Topics: Adult; Aged; Aged, 80 and over; Carotid Arteries; Carotid Stenosis; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1996 |
Acute transverse myelitis after influenza vaccination: magnetic resonance imaging findings.
Topics: Acute Disease; Adult; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Hypertrophy; Image Enhancement; Influenza Vaccines; Magnetic Resonance Imaging; Meglumine; Myelitis, Transverse; Organometallic Compounds; Pentetic Acid; Spinal Cord; Vaccination | 1996 |
Gadolinium-enhanced MR imaging of the spleen: artifacts and potential pitfalls.
Topics: Aged; Artifacts; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Spleen; Splenic Diseases | 1996 |
Magnetic resonance imaging in coccidioidal arthritis.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Infectious; Coccidioidomycosis; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Joints; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Synovial Membrane | 1996 |
Magnetic resonance imaging of abscesses of the brain stem and cerebellum complicating Listeria monocytogenes rhombencephalitis.
Topics: Aged; Brain Abscess; Brain Stem; Cerebellar Diseases; Contrast Media; Drug Combinations; Encephalitis; Gadolinium; Gadolinium DTPA; Humans; Listeria monocytogenes; Listeriosis; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Rhombencephalon | 1996 |
[MR mammography of fatty tissue necrosis].
Topics: Adult; Aged; Breast Diseases; Contrast Media; Diagnosis, Differential; Drug Combinations; Evaluation Studies as Topic; Fat Necrosis; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Retrospective Studies; Ultrasonography, Mammary | 1996 |
[MRT of experimental liver abscesses: a comparison of a new blood pool contrast medium with gadolinium-DTPA in animal experiments].
Topics: Animals; Contrast Media; Drug Combinations; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Liver Abscess; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Rabbits; Suppuration; Time Factors | 1996 |
Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
Topics: Animals; Disease Models, Animal; Fusobacterium Infections; Gadolinium; Heterocyclic Compounds; Image Enhancement; Infusions, Intravenous; Liver Abscess; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rabbits | 1996 |
Suppression of venous signal in time-of-flight MR angiography of the lower extremities after administration of gadopentetate dimeglumine.
Topics: Aged; Aged, 80 and over; Arteries; Blood Flow Velocity; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Leg; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Muscle, Skeletal; Organometallic Compounds; Pentetic Acid; Peripheral Vascular Diseases; Veins | 1997 |
Thoracic aorta: comparison of gadolinium-enhanced three-dimensional MR angiography with conventional MR imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Coarctation; Aortic Diseases; Aortic Dissection; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Infant, Newborn; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Retrospective Studies | 1997 |
Mesenteric circulation: three-dimensional MR angiography with a gadolinium-enhanced multiecho gradient-echo technique.
Topics: Adult; Aged; Celiac Artery; Contrast Media; Drug Combinations; Fasting; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Angiography; Male; Meglumine; Mesenteric Arteries; Mesenteric Vascular Occlusion; Mesenteric Veins; Middle Aged; Organometallic Compounds; Pentetic Acid; Portal Vein | 1997 |
Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hepatic Artery; Humans; Injections; Liver; Liver Circulation; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Portal Vein | 1997 |
Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography.
Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Infant, Newborn; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1997 |
Magnetic resonance detection of acute pulmonary emboli in a canine model with pathologic correlation.
Topics: Acute Disease; Angiography; Animals; Contrast Media; Disease Models, Animal; Dissection; Dogs; Drug Combinations; Gadolinium; Gadolinium DTPA; Image Enhancement; Lung; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pulmonary Embolism; Sensitivity and Specificity | 1996 |
Gadopentetate dimeglumine and iodinated contrast media. Hemodynamic side effects after bolus injections in pigs.
Topics: Animals; Contrast Media; Diatrizoate; Dose-Response Relationship, Drug; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heart Ventricles; Hemodynamics; Injections; Iopamidol; Meglumine; Organometallic Compounds; Pentetic Acid; Swine | 1997 |
MR imaging of musculoskeletal tumors and tumor mimickers with intravenous gadolinium: experience with 242 patients.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Muscle Neoplasms; Neoplasms, Connective Tissue; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity | 1997 |
Benign and malignant musculoskeletal masses: MR imaging differentiation with rim-to-center differential enhancement ratios.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Muscle Neoplasms; Organometallic Compounds; Pentetic Acid | 1997 |
Gadolinium-enhanced MR imaging of thyroid and parathyroid masses.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Parathyroid Neoplasms; Pentetic Acid; Thyroid Neoplasms | 1997 |
Magnetic resonance imaging contrast media in the subarachnoid space. A comparison between gadodiamide injection and gadopentetate dimeglumine in an experimental study in pigs.
Topics: Animals; Blood Pressure; Cerebrospinal Fluid Pressure; Cerebrospinal Fluid Proteins; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Injections, Spinal; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Subarachnoid Space; Swine | 1997 |
Saline versus gadolinium-enhanced magnetic resonance arthrography of porcine cartilage.
Topics: Animals; Cartilage, Articular; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Observer Variation; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity; Sodium Chloride; Swine | 1997 |
Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
Topics: Adult; Contrast Media; Drug Combinations; Drug Hypersensitivity; Gadolinium; Gadolinium DTPA; Humans; Iohexol; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Tomography, X-Ray Computed | 1997 |
Gadolinium-enhanced magnetic resonance angiography of renal transplants.
Topics: Adolescent; Adult; Anastomosis, Surgical; Angiography; Arterial Occlusive Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Iliac Artery; Image Enhancement; Image Processing, Computer-Assisted; Kidney Transplantation; Magnetic Resonance Angiography; Male; Meglumine; Observer Variation; Organometallic Compounds; Pentetic Acid; Prospective Studies; Renal Artery; Renal Artery Obstruction; Sensitivity and Specificity | 1997 |
Comparison of cardiovascular changes after administration of gadodiamide injection and gadopentetate dimeglumine in dogs.
Topics: Animals; Contrast Media; Dogs; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hemodynamics; Injections, Intravenous; Male; Meglumine; Organometallic Compounds; Pentetic Acid | 1997 |
Acute cardiotoxicity of gadolinium-based contrast media: findings in the isolated rat heart.
Topics: Animals; Arrhythmias, Cardiac; Contrast Media; Drug Combinations; Electrocardiography; Gadolinium; Gadolinium DTPA; Heart; Heart Rate; Heterocyclic Compounds; In Vitro Techniques; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Pressure | 1997 |
Contrast-enhanced abdominal MR angiography: optimization of imaging delay time by automating the detection of contrast material arrival in the aorta.
Topics: Abdomen; Aorta; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1997 |
Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast.
Topics: Adolescent; Adult; Aged; Aging; Breast; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Menstrual Cycle; Middle Aged; Organometallic Compounds; Pentetic Acid | 1997 |
Pulmonary embolism: detection with MR perfusion imaging of lung--a feasibility study.
Topics: Adult; Aged; Contrast Media; Drug Combinations; Feasibility Studies; Female; Gadolinium; Gadolinium DTPA; Humans; Lung; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pulmonary Embolism; Radionuclide Imaging; Ventilation-Perfusion Ratio | 1997 |
T2*-weighted dynamic MR imaging in renal artery or vein stenosis.
Topics: Adult; Constriction, Pathologic; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Renal Artery Obstruction; Renal Veins | 1997 |
Dynamic gadolinium-enhanced subtraction MR imaging--a simple technique for the early diagnosis of Legg-Calvé-Perthes disease: preliminary results.
Topics: Child; Child, Preschool; Contrast Media; Female; Gadolinium; Hip Joint; Humans; Legg-Calve-Perthes Disease; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Radiography; Radionuclide Imaging; Sensitivity and Specificity; Subtraction Technique | 1997 |
CT and MR findings of denervated tongue after radical neck dissection.
Topics: Adult; Aged; Atrophy; Carcinoma, Squamous Cell; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Head and Neck Neoplasms; Humans; Hypoglossal Nerve; Hypoglossal Nerve Injuries; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neck Dissection; Nerve Degeneration; Organometallic Compounds; Paralysis; Pentetic Acid; Retrospective Studies; Tomography, X-Ray Computed; Tongue; Tongue Diseases | 1997 |
Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR.
Topics: Acromegaly; Adenoma; Adult; Aged; Antineoplastic Agents, Hormonal; Contrast Media; Drug Combinations; Evaluation Studies as Topic; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Hemorrhage; Human Growth Hormone; Humans; Image Enhancement; Insulin-Like Growth Factor I; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Necrosis; Octreotide; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Remission Induction | 1997 |
Potential neurotoxic effects of gadopentetate dimeglumine: clinical significance.
Topics: Age Factors; Animals; Blood-Brain Barrier; Brain; Child, Preschool; Contrast Media; Disease Models, Animal; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Infant; Infant, Newborn; Injections, Intravenous; Injections, Spinal; Iodides; Meglumine; Organometallic Compounds; Pentetic Acid; Rats | 1997 |
MR imaging in retinoblastoma.
Topics: Contrast Media; Drug Combinations; Eye; Eye Enucleation; Eye Neoplasms; Gadolinium; Gadolinium DTPA; Humans; Infant; Magnetic Resonance Imaging; Meglumine; Neoplasm Staging; Organometallic Compounds; Pentetic Acid; Preoperative Care; Retinoblastoma | 1997 |
Accuracy of staging rectal tumors with contrast-enhanced transrectal MR imaging.
Topics: Adenoma, Villous; Carcinoma; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Muscle, Smooth; Neoplasm Staging; Organometallic Compounds; Pentetic Acid; Rectal Neoplasms; Rectum | 1997 |
Stromal invasion by carcinoma of the cervix: assessment with dynamic MR imaging.
Topics: Adenocarcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cervix Uteri; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoplasm Invasiveness; Organometallic Compounds; Pentetic Acid; Stromal Cells; Uterine Cervical Neoplasms | 1997 |
Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.
Topics: Aged; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Observer Variation; Organometallic Compounds; Pentetic Acid; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Subtraction Technique | 1997 |
Hepatic lesion detection at MR imaging: a comparative study with four sequences.
Topics: Adipose Tissue; Adult; Aged; Area Under Curve; Contrast Media; Drug Combinations; Female; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Hepatectomy; Humans; Image Enhancement; Image Processing, Computer-Assisted; Iron; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Oxides; Pentetic Acid; Preoperative Care; ROC Curve; Sensitivity and Specificity; Single-Blind Method | 1997 |
Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation.
Topics: Adult; Aged; Amputation, Surgical; Bone Marrow Diseases; Contrast Media; Diabetic Foot; Diagnostic Techniques, Surgical; Drug Combinations; Edema; False Positive Reactions; Female; Foot Diseases; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Osteomyelitis; Patient Care Planning; Pentetic Acid; Reproducibility of Results; Sensitivity and Specificity | 1997 |
Lung perfusion demonstrated by contrast-enhanced dynamic magnetic resonance imaging. Application to unilateral lung transplantation.
Topics: Adult; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Lung; Lung Transplantation; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Radionuclide Imaging | 1997 |
[Osteoporotic stress fractures of the sacrum: MR-tomography findings].
Topics: Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Fractures, Stress; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Osteoporosis; Pentetic Acid; Sacrum; Tomography, X-Ray Computed | 1997 |
Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Cysts; Drug Combinations; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Hemangioma, Cavernous; Hepatic Artery; Humans; Image Enhancement; Injections, Intra-Arterial; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Respiration; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method | 1997 |
Evaluation of renal artery stenosis with dynamic gadolinium-enhanced MR angiography.
Topics: Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Radiography; Renal Artery; Renal Artery Obstruction; Retrospective Studies; Sensitivity and Specificity | 1997 |
High-resolution MR imaging of the anal sphincter in children: a pilot study using endoanal receiver coils.
Topics: Adolescent; Anal Canal; Child; Child, Preschool; Contrast Media; Drug Combinations; Fecal Incontinence; Female; Gadolinium; Gadolinium DTPA; Humans; Infant; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Pilot Projects; Rectal Diseases | 1997 |
Intracranial meningeomas: time- and dose-dependent effects of irradiation on tumor microcirculation monitored by dynamic MR imaging.
Topics: Contrast Media; Dose-Response Relationship, Radiation; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Meningeal Neoplasms; Meningioma; Microcirculation; Middle Aged; Organometallic Compounds; Pentetic Acid; Radiotherapy Dosage; Radiotherapy, High-Energy; Time Factors | 1997 |
Ex-vivo MR imaging of liver intracellular contrast agents.
Topics: Animals; Contrast Media; Female; Ferrosoferric Oxide; Gadolinium; Iron; Liver; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Oxides; Rats; Rats, Wistar | 1997 |
Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography.
Topics: Angiography, Digital Subtraction; Aorta, Abdominal; Aortic Diseases; Arterial Occlusive Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Iliac Aneurysm; Iliac Artery; Image Processing, Computer-Assisted; Ioxaglic Acid; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Renal Artery Obstruction; Sensitivity and Specificity | 1997 |
Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging.
Topics: Animals; Cardiac Catheterization; Contrast Media; Coronary Angiography; Coronary Circulation; Coronary Disease; Drug Combinations; Feasibility Studies; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Microvascular Angina; Middle Aged; Myocardium; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity; Swine; Time Factors; Ultrasonography, Interventional | 1997 |
Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
Topics: Administration, Oral; Barium Sulfate; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Glucagon; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Peritoneal Neoplasms; Prospective Studies; Pseudomyxoma Peritonei; Sensitivity and Specificity; Tomography, X-Ray Computed | 1997 |
Optimal MR protocol for hepatic hemangiomas. Comparison of conventional spin-echo sequences with T2-weighted turbo spin-echo and serial gradient-echo (FLASH) sequences with gadolinium enhancement.
Topics: Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1997 |
Meglumine gadoterate: a new safe radiocontrast medium for endoscopic retrograde cholangiopancreatography?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biliary Tract; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Female; Gadolinium; Gallstones; Humans; Iothalamic Acid; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Ducts; Pancreatitis; Radiographic Image Enhancement | 1997 |
Dynamic T1 measurement using snapshot-FLASH MRI.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Myocardial Infarction; Myocardium; Organometallic Compounds; Phantoms, Imaging | 1997 |
Nontumorous hepatic pseudolesion around the falciform ligament: prevalence on gadolinium chelate-enhanced MR examination.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Ligaments; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies | 1997 |
Sonographic guidance of needle position for MR arthrography of the shoulder.
Topics: Adult; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Injections, Intra-Articular; Joint Instability; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Shoulder Impingement Syndrome; Shoulder Joint; Ultrasonography, Interventional | 1997 |
The use of gadolinium in the MR imaging of bone tumors.
Topics: Antineoplastic Agents; Bone Neoplasms; Contrast Media; Drug Combinations; Edema; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Joint Diseases; Magnetic Resonance Imaging; Meglumine; Muscle, Skeletal; Muscular Diseases; Necrosis; Neoplasm Staging; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Sarcoma; Sensitivity and Specificity; Treatment Outcome | 1997 |
Detectability of small liver metastases with gadolinium BOPTA.
Topics: Adenocarcinoma; Animals; Contrast Media; Gadolinium; Heterocyclic Compounds; Infusions, Intravenous; Liver; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Meglumine; Neoplasm Transplantation; Organometallic Compounds; Prospective Studies; Rabbits; Random Allocation | 1997 |
MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Topics: Administration, Oral; Aged; Aged, 80 and over; Barium Sulfate; Contrast Media; Digestive System; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Gastrointestinal Diseases; Humans; Injections, Intravenous; Intestines; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Retrospective Studies; Tomography, X-Ray Computed | 1997 |
MR imaging of ureteropelvic junction obstruction.
Topics: Adult; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Kidney Pelvis; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Ureteral Obstruction | 1997 |
Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Arterial Occlusive Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Leg; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity | 1997 |
Pathologic conditions in the small bowel: findings at fat-suppressed gadolinium-enhanced MR imaging with an optimized suspension of oral magnetic particles.
Topics: Administration, Oral; Adolescent; Adult; Animals; Cattle; Contrast Media; Drug Combinations; Female; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; In Vitro Techniques; Intestinal Diseases; Intestine, Small; Iron; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Oxides; Pentetic Acid | 1997 |
Magnetic resonance-guided laparoscopic interstitial laser therapy of the liver.
Topics: Animals; Contrast Media; Female; Gadolinium; Laparoscopy; Laser Coagulation; Liver; Magnetic Resonance Imaging; Meglumine; Minimally Invasive Surgical Procedures; Organometallic Compounds; Swine | 1997 |
Multislice measurement of first-pass transit of gadobenate dimeglumine in normal and ischemic myocardium in dogs.
Topics: Animals; Contrast Media; Dogs; Gadolinium; Magnetic Resonance Imaging; Meglumine; Myocardial Ischemia; Myocardium; Organometallic Compounds | 1995 |
Annular tears and disk herniation: prevalence and contrast enhancement on MR images in the absence of low back pain or sciatica.
Topics: Adult; Age Factors; Case-Control Studies; Contrast Media; Female; Gadolinium; Humans; Intervertebral Disc Displacement; Low Back Pain; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Prevalence; Sciatica | 1998 |
Detection of breast cancer with conventional mammography and contrast-enhanced MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast; Breast Neoplasms; Contrast Media; False Negative Reactions; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Mammography; Meglumine; Middle Aged; Organometallic Compounds; ROC Curve; Sensitivity and Specificity | 1998 |
Mismatch between cerebral blood volume and flow index during transient focal ischemia studied with MRI and GD-BOPTA.
Topics: Animals; Blood Volume; Cats; Cerebrovascular Circulation; Contrast Media; Gadolinium; Ischemic Attack, Transient; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 1998 |
Is it dangerous to inject magnetic resonance contrast media into the subarachnoid space?
Topics: Animals; Blood-Brain Barrier; Brain; Contrast Media; Dyskinesia, Drug-Induced; Gadolinium; Image Enhancement; Injections, Spinal; Iodine; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rats; Subarachnoid Space | 1998 |
Multihance clinical pharmacology: biodistribution and MR enhancement of the liver.
Topics: Contrast Media; Gadolinium; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Single-Blind Method | 1998 |
Evaluation of Gd-DOTA-labeled dextran polymer as an intravascular MR contrast agent for myocardial perfusion.
Topics: Animals; Contrast Media; Coronary Circulation; Gadolinium; Heterocyclic Compounds; In Vitro Techniques; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Swine | 1998 |
High-performance liquid chromatographic determination of the magnetic resonance imaging contrast agent gadobenate ion in plasma, urine, faeces, bile and tissues.
Topics: Animals; Bile; Cattle; Chromatography, High Pressure Liquid; Contrast Media; Feces; Gadolinium; Humans; Liver; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rats; Spectrophotometry, Ultraviolet | 1998 |
Closed ruptures of the flexor digitorum tendons: MRI evaluation.
Topics: Adult; Contrast Media; Female; Finger Injuries; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Patient Care Planning; Retrospective Studies; Rupture; Tendon Injuries; Tendons; Wounds, Nonpenetrating | 1998 |
Assessment of myocardial function and perfusion in a canine model of non-occlusive coronary artery stenosis using fast magnetic resonance imaging.
Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Dipyridamole; Dogs; Gadolinium; Magnetic Resonance Imaging; Meglumine; Myocardial Contraction; Myocardial Ischemia; Myocardium; Organometallic Compounds; Vasodilator Agents; Ventricular Function, Left | 1999 |
Neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia: EEG evaluation.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Contrast Media; Electroencephalography; Gadolinium; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Rats | 1999 |
Capsule of hepatocellular carcinoma: where and how does the capsule show enhancement?
Topics: Carcinoma, Hepatocellular; Contrast Media; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 1999 |
Infarcted myocardium in pigs: MR imaging enhanced with slow-interstitial-diffusion gadolinium compound P760.
Topics: Animals; Contrast Media; Female; Gadolinium; Magnetic Resonance Imaging; Meglumine; Myocardial Infarction; Myocardium; Organometallic Compounds; Swine | 1999 |
Gd-BOPTA: "the MRA contrast agent of choice"?
Topics: Aortic Valve Stenosis; Chelating Agents; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds; Subclavian Artery; Vascular Diseases | 1999 |
Neurotolerability of gadobenate dimeglumine. Evaluation of brain dopamine concentration in freely moving rats by microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Contrast Media; Dopamine; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Homovanillic Acid; Magnetic Resonance Imaging; Male; Meglumine; Microdialysis; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 1999 |
Pharmacokinetics and tissue distribution in animals of gadobenate ion, the magnetic resonance imaging contrast enhancing component of gadobenate dimeglumine 0.5 M solution for injection (MultiHance).
Topics: Animals; Autoradiography; Bile; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Contrast Media; Dogs; Feces; Female; Gadolinium; Injections, Intravenous; Kidney; Liver; Macaca fascicularis; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pregnancy; Rabbits; Rats; Rats, Sprague-Dawley; Spectrometry, X-Ray Emission; Tissue Distribution; Urine | 1999 |
General pharmacology in experimental animals of gadobenate dimeglumine (MultiHance), a new magnetic resonance imaging contrast agent.
Topics: Animals; Blood-Brain Barrier; Contrast Media; Drug Hypersensitivity; Gadolinium; Guinea Pigs; Heart; Hemodynamics; Injections, Intravenous; Kidney; Liver; Lung; Magnetic Resonance Imaging; Male; Meglumine; Mononuclear Phagocyte System; Myocardial Ischemia; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Swine; Swine, Miniature | 1999 |
Toxicological safety evaluation of gadobenate dimeglumine 0.5 M solution for injection (MultiHance), a new magnetic resonance imaging contrast medium.
Topics: Animals; Contrast Media; Female; Gadolinium; Humans; Injections, Intravenous; Macaca fascicularis; Magnetic Resonance Imaging; Male; Meglumine; Mice; Mice, Inbred ICR; Mutagenesis; Organometallic Compounds; Pregnancy; Rabbits; Rats; Rats, Sprague-Dawley; Reproduction; Safety | 1999 |
[General toxicity study of gadobenate dimeglumine formulation (E7155) (1)--single dose intravenous and intracisternal toxicity study in rats].
Topics: Animals; Cisterna Magna; Contrast Media; Female; Gadolinium; Injections; Injections, Intravenous; Lethal Dose 50; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 1999 |
[General toxicity study of gadobenate dimeglumine formulation (E7155) (2)--Single dose intravenous toxicity study in dogs].
Topics: Animals; Blood Chemical Analysis; Body Weight; Contrast Media; Dogs; Eating; Female; Gadolinium; Hematologic Tests; Injections, Intravenous; Lethal Dose 50; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Urinalysis | 1999 |
[General toxicity study of gadobenate dimeglumine formulation (E7155) (3)--4-week repeated dose intravenous toxicity study followed by 4-week recovery period in rats].
Topics: Animals; Blood Chemical Analysis; Body Weight; Contrast Media; Drinking; Eating; Eye; Female; Gadolinium; Hematologic Tests; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Organ Size; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Time Factors; Urinalysis | 1999 |
[General toxicity study of gadobenate dimeglumine formulation (E7155) (4)--4-week repeated dose intravenous toxicity study followed by 4-week recovery period in dogs].
Topics: Animals; Body Weight; Contrast Media; Dogs; Drinking; Eating; Electrocardiography; Female; Gadolinium; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Time Factors; Urinalysis | 1999 |
[Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155) (1)--Fertility study in male rats by intravenous administration].
Topics: Animals; Body Weight; Contrast Media; Female; Fertility; Gadolinium; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Organ Size; Organometallic Compounds; Pregnancy; Rats; Rats, Sprague-Dawley; Sperm Count; Sperm Motility | 1999 |
[Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155) (2)--Combined study of effects on fertility and embryo-fetal toxicity in female rats by intravenous administration].
Topics: Animals; Contrast Media; Embryo, Mammalian; Estrus; Female; Fertility; Fetus; Gadolinium; Injections, Intravenous; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 1999 |
[Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155) (3)--Study of embryo-fetal toxicity in rabbits by intravenous administration].
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Contrast Media; Embryo, Mammalian; Female; Fetal Death; Fetus; Gadolinium; Injections, Intravenous; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rabbits; Teratogens | 1999 |
[Mutagenicity study of gadobenate dimeglumine formulation (E7155) (1)--Reverse mutation assays in S. typhimurium and E. coli tester strains].
Topics: Contrast Media; Escherichia coli; Gadolinium; Magnetic Resonance Imaging; Meglumine; Mutagenicity Tests; Mutagens; Organometallic Compounds; Salmonella typhimurium | 1999 |
[Mutagenicity study of gadobenate dimeglumine formulation (E7155) (2)--Chromosome aberration test with human lymphocytes in culture].
Topics: Animals; Cells, Cultured; Chromosome Aberrations; Contrast Media; Gadolinium; Humans; Lymphocytes; Magnetic Resonance Imaging; Male; Meglumine; Mutagenicity Tests; Mutagens; Organometallic Compounds; Rats | 1999 |
[Mutagenicity study of gadobenate dimeglumine formulation (E7155) (3)--Micronucleus test in rat bone marrow cells].
Topics: Animals; Bone Marrow Cells; Contrast Media; Female; Gadolinium; Injections, Intraperitoneal; Male; Meglumine; Micronucleus Tests; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 1999 |
[Muscular irritation study of gadobenate dimeglumine formulation (E7155) in rabbits].
Topics: Animals; Contrast Media; Gadolinium; Injections, Intramuscular; Irritants; Magnetic Resonance Imaging; Male; Meglumine; Muscle, Skeletal; Necrosis; Organometallic Compounds; Rabbits | 1999 |
Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Time Factors | 2000 |
Stretch-activated ion channels contribute to membrane depolarization after eccentric contractions.
Topics: Amiloride; Animals; Cations; Cell Membrane Permeability; Female; Gadolinium; Ion Channels; Mechanoreceptors; Meglumine; Membrane Potentials; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Skeletal; Physical Conditioning, Animal; Potassium; Rats; Rats, Sprague-Dawley; Sodium; Sodium Channel Blockers; Sodium Channels; Sodium-Hydrogen Exchangers; Streptomycin; Tetrodotoxin | 2000 |
Physical, chemical, and biological evaluations of P760: a new gadolinium complex characterized by a low rate of interstitial diffusion.
Topics: Animals; Capillary Permeability; Contrast Media; Diffusion; Endothelium, Vascular; Gadolinium; Male; Meglumine; Mice; Organometallic Compounds; Rabbits; Rats; Rats, Wistar; Tissue Distribution | 2000 |
Cardiac effects of contrast media in MR angiography: evaluation in an experimental model of myocardial ischemia.
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heart; Heart Rate; In Vitro Techniques; Magnetic Resonance Angiography; Male; Meglumine; Myocardial Ischemia; Myocardial Reperfusion; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Ventricular Pressure | 1999 |
Gadobenate dimeglumine and cerebral glucose metabolism. Continuous monitoring of striatal lactate levels in freely moving rats.
Topics: Animals; Brain; Contrast Media; Corpus Striatum; Gadolinium; Glucose; Lactic Acid; Male; Meglumine; Microdialysis; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 2000 |
A calcium-activated cation current by an alternatively spliced form of Trp3 in the heart.
Topics: Adenosine Triphosphate; Alternative Splicing; Amino Acid Sequence; Amino Acids; Animals; Blotting, Northern; Blotting, Western; Brain; Calcium; Calcium Channels; Cations; Chlorides; Cloning, Molecular; DNA, Complementary; Enzyme Inhibitors; Gadolinium; Indicators and Reagents; Ionomycin; Ionophores; Meglumine; Molecular Sequence Data; Myocardium; Oocytes; Patch-Clamp Techniques; Phorbol Esters; Potassium; Rats; Reverse Transcriptase Polymerase Chain Reaction; Ruthenium Red; Sequence Homology, Amino Acid; Sodium; Tetraethylammonium; Thapsigargin; Tissue Distribution; TRPC Cation Channels; Xenopus | 2000 |
Feasibility of synchrotron radiation computed tomography on rats bearing glioma after iodine or gadolinium injection. Jeune Equipe RSRM-UJF.
Topics: Animals; Brain Neoplasms; Contrast Media; Feasibility Studies; Female; Gadolinium; Glioma; Ioxaglic Acid; Meglumine; Organometallic Compounds; Rats; Rats, Wistar; Synchrotrons; Tomography, X-Ray Computed; Tumor Cells, Cultured | 2000 |
Nonselective cation channels as effectors of free radical-induced rat liver cell necrosis.
Topics: Animals; Calcium; Calcium Channel Blockers; Cations; Cells, Cultured; Electric Conductivity; Extracellular Space; Free Radicals; Gadolinium; Ion Channels; Liver; Meglumine; Naphthalenes; Necrosis; ortho-Aminobenzoates; Oxidative Stress; Rats; Sodium; Vitamin K | 2001 |
[Gd-BOPTA enhanced excretory MR urography without administration of diuretics].
Topics: Adult; Diuretics; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Pelvic Neoplasms; Reproducibility of Results; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urography; Urologic Neoplasms | 2001 |
Mediastinal lymphoma: quantitative changes in gadolinium enhancement at MR imaging after treatment.
Topics: Adult; Combined Modality Therapy; Contrast Media; Female; Follow-Up Studies; Gadolinium; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Meglumine; Neoplasm, Residual; Organometallic Compounds; Prospective Studies; Time Factors | 2001 |
A standing Na+ conductance in rat carotid body type I cells.
Topics: Acid-Base Equilibrium; Acidosis, Respiratory; Amiloride; Animals; Carotid Body; Cells, Cultured; Choline; Gadolinium; Homeostasis; Hydrogen-Ion Concentration; Hypoxia; Lithium; Meglumine; Membrane Potentials; Oxygen; Patch-Clamp Techniques; Potassium Channels; Rats; Signal Transduction; Sodium; Sodium Channels; Tetrodotoxin; Zinc | 2001 |
Comparative study between gadobenate dimeglumine and gadobutrol in rats with brain ischemia: evaluation of somatosensory evoked potentials.
Topics: Animals; Brain Ischemia; Contrast Media; Evoked Potentials, Somatosensory; Gadolinium; Iohexol; Male; Meglumine; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 2001 |
Bile-tagged 3d magnetic resonance colonography after exclusive intravenous administration of gadobenate dimeglumine, a contrast agent with partial hepatobiliary excretion.
Topics: Adult; Bile; Colon; Contrast Media; Feasibility Studies; Gadolinium; Gallbladder; Humans; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Time Factors | 2001 |
Coronary magnetic resonance angiography: experimental evaluation of the new rapid clearance blood pool contrast medium P792.
Topics: Animals; Contrast Media; Coronary Vessels; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds; Swine; Swine, Miniature | 2001 |
Solitary hepatic infantile hemangioendothelioma: dynamic gadolinium-enhanced MR imaging findings.
Topics: Contrast Media; Female; Gadolinium; Hemangioendothelioma; Humans; Infant, Newborn; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2002 |
Lumbar spinal ganglia enhancement after gadolinium chelate administration: a radio-histological correlation.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Ganglia, Spinal; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2001 |
Optimization of contrast dosage for gadobenate dimeglumine-enhanced high-resolution whole-body 3D magnetic resonance angiography.
Topics: Adult; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Male; Meglumine; Organometallic Compounds | 2002 |
Gadolinium-enhanced digital subtraction angiography of hemodialysis fistulas: a diagnostic and therapeutic approach.
Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Angioplasty, Balloon; Arteriovenous Shunt, Surgical; Constriction, Pathologic; Contrast Media; Feasibility Studies; Female; Gadolinium; Graft Occlusion, Vascular; Humans; Male; Meglumine; Middle Aged; Organometallic Compounds; Radiography, Interventional; Renal Dialysis; Retrospective Studies; Thrombosis | 2002 |
Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations.
Topics: Colorectal Neoplasms; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Gadolinium; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Middle Aged; Organometallic Compounds; Oxides; Suspensions | 2002 |
Nonselective cation currents regulate membrane potential of rabbit coronary arterial cell: modulation by lysophosphatidylcholine.
Topics: Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Cesium; Coronary Vessels; Dose-Response Relationship, Drug; Electric Stimulation; Gadolinium; Intracellular Fluid; Ion Channels; Lanthanum; Lysophosphatidylcholines; Male; Meglumine; Membrane Potentials; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Potassium; Potassium Channel Blockers; Rabbits; Sodium | 2002 |
Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine, and gadobutrol for pelvic 3D magnetic resonance angiography.
Topics: Adult; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Iliac Artery; Image Enhancement; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Male; Meglumine; Organometallic Compounds; Pelvis | 2003 |
Preoperative evaluation of living renal donors: value of contrast-enhanced 3D magnetic resonance angiography and comparison of three rendering algorithms.
Topics: Algorithms; Angiography, Digital Subtraction; Contrast Media; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kidney Transplantation; Living Donors; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Artery; Sensitivity and Specificity | 2003 |
Improved MR coronary angiography with use of a new rapid clearance blood pool contrast agent in pigs.
Topics: Animals; Contrast Media; Coronary Vessels; Female; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds; Swine; Time Factors | 2003 |
MR angiography of the carotid arteries: parameters affecting image quality.
Topics: Aged; Aged, 80 and over; Carotid Arteries; Carotid Artery Diseases; Contrast Media; Female; Fluoroscopy; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Male; Meglumine; Organometallic Compounds | 2003 |
Determination of dissociation constants of (4RS)-[4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oic acid] in water and biological fluids by means of nuclear magnetic resonance spectroscopy and the DISCO software package.
Topics: Carbon Isotopes; Deuterium Oxide; Gadolinium; Humans; Hydrogen-Ion Concentration; Isotonic Solutions; Kinetics; Magnetic Resonance Spectroscopy; Meglumine; Organometallic Compounds; Serum; Sodium Chloride; Software; Thermodynamics; Water | 2003 |
Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation.
Topics: Animals; Biological Transport; Contrast Media; Gadolinium; Gadolinium DTPA; In Vitro Techniques; Liver; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Oxygen Consumption; Portal Pressure; Rats; Rats, Sprague-Dawley; Sulfobromophthalein | 2003 |
Intracranial aneurysms treated with Guglielmi detachable coils: is contrast material necessary in the follow-up with 3D time-of-flight MR angiography?
Topics: Angiography, Digital Subtraction; Contrast Media; Embolization, Therapeutic; Female; Gadolinium; Humans; Imaging, Three-Dimensional; Intracranial Aneurysm; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Recurrence; Sensitivity and Specificity | 2003 |
MRI findings in lingual venous malformations.
Topics: Adolescent; Adult; Arteriovenous Malformations; Child; Contrast Media; Diagnosis, Differential; Epiglottis; Female; Gadolinium; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Mouth Floor; Organometallic Compounds; Retrospective Studies; Tongue | 2003 |
Gd-BOPTA transport into rat hepatocytes: pharmacokinetic analysis of dynamic magnetic resonance images using a hollow-fiber bioreactor.
Topics: Animals; Biological Transport; Bioreactors; Contrast Media; Gadolinium; Gadolinium DTPA; Hepatocytes; In Vitro Techniques; Magnetic Resonance Imaging; Male; Meglumine; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 2004 |
Technological advances and clinical trends in MRI.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2004 |
Hysterosalpingography with gadolinium.
Topics: Adult; Contrast Media; Female; Fluoroscopy; Gadolinium; Humans; Hysterosalpingography; Meglumine; Organometallic Compounds | 2005 |
Proceedings of the MultiHance (gadobenate dimeglumine) user group meeting. December 19-20, 2003. Rome, Italy.
Topics: Clinical Trials as Topic; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2004 |
Magnetic resonance imaging of myocardial infarction using gadolinium-based contrast agent.
Topics: Contrast Media; Feasibility Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Myocardial Infarction; Organometallic Compounds; Prospective Studies | 2004 |
A protocol to evaluate myocardial viability in ischemic left ventricular dysfunction using magnetic resonance imaging and a gadolinium-based contrast agent.
Topics: Clinical Protocols; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Myocardial Ischemia; Myocardium; Organometallic Compounds; Prospective Studies; Ventricular Dysfunction, Left | 2004 |
Uterine restoration after repeated sloughing of fibroids or vaginal expulsion following uterine artery embolization.
Topics: Abdominal Pain; Adult; Arteries; Contrast Media; Embolization, Therapeutic; Female; Follow-Up Studies; Gadolinium; Hemostatics; Humans; Hysteroscopy; Leiomyoma; Magnetic Resonance Imaging; Meglumine; Middle Aged; Necrosis; Organometallic Compounds; Polyvinyl Alcohol; Retrospective Studies; Safety; Time Factors; Treatment Outcome; Uterine Neoplasms; Uterus; Vaginal Discharge | 2005 |
Evaluation of steady state free precession imaging of the pancreas.
Topics: Contrast Media; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreas; Pancreatic Diseases; Pancreatic Pseudocyst; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2005 |
Determinants of myocardial response in CMR perfusion imaging using Gd-BOPTA (Multihance).
Topics: Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium; Heart Ventricles; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Pilot Projects | 2005 |
Preoperative MRI of potential living-donor-related liver transplantation using a single dose of gadobenate dimeglumine.
Topics: Adolescent; Adult; Bile Ducts; Contrast Media; Feasibility Studies; Female; Gadolinium; Hepatic Artery; Hepatic Veins; Humans; Liver; Liver Transplantation; Living Donors; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Portal Vein | 2005 |
How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity.
Topics: Animals; Contrast Media; Gadolinium; Heterocyclic Compounds; Injections, Intravenous; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds; Rabbits | 2005 |
MRI evaluation of myometrial invasion by endometrial carcinoma. Comparison between fast-spin-echo T2w and coronal-FMPSPGR Gadolinium-Dota-enhanced sequences.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Endometrial Neoplasms; Endometrium; Female; Gadolinium; Humans; Hysterectomy; Magnetic Resonance Imaging; Meglumine; Middle Aged; Myometrium; Neoplasm Invasiveness; Neoplasm Staging; Organometallic Compounds; Postmenopause; Predictive Value of Tests; Sensitivity and Specificity | 2005 |
Contrast material-enhanced visualization of the ablation medium for magnetic resonance-monitored ethanol injection therapy: imaging and safety aspects.
Topics: Arteriovenous Malformations; Contrast Media; Ethanol; Gadolinium; Humans; Image Enhancement; Injections, Intralesional; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Protons; Solubility; Time Factors; Water | 2006 |
MR angiography versus intra-arterial digital subtraction angiography of the lower extremities: activity-based cost analysis.
Topics: Angiography, Digital Subtraction; Contrast Media; Costs and Cost Analysis; Europe; Gadolinium; Humans; Leg; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds | 2006 |
MRI evaluation of bulky tumor masses in the mesentery and bladder involvement in peritoneal carcinomatosis.
Topics: Carcinoma; Contrast Media; Gadolinium; Humans; Intestinal Neoplasms; Intestines; Magnetic Resonance Imaging; Meglumine; Mesentery; Organometallic Compounds; Peritoneal Neoplasms; Urinary Bladder; Urinary Bladder Neoplasms | 2006 |
Toxicological assessment of gadolinium release from contrast media.
Topics: Animals; Contrast Media; Drug Stability; Gadolinium; Gadolinium DTPA; Male; Meglumine; Organ Specificity; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2007 |
Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study.
Topics: Angiography; Animals; Apoptosis; Cell Death; Coloring Agents; Contrast Media; Gadolinium; Gadolinium DTPA; Iodine; Iopamidol; Kidney Tubules, Proximal; LLC-PK1 Cells; Mannitol; Meglumine; Necrosis; Organometallic Compounds; Swine; Tetrazolium Salts; Thiazoles; Trypan Blue | 2007 |
Case 106: aggressive angiomyxoma.
Topics: Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Middle Aged; Myxoma; Organometallic Compounds; Vulvar Neoplasms | 2007 |
Contrast enhanced cartilage imaging: Comparison of ionic and non-ionic contrast agents.
Topics: Animals; Arthrography; Cartilage, Articular; Cattle; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Patellar Ligament; Pyridoxal Phosphate; Sodium Chloride; Time Factors | 2007 |
Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Topics: Adult; Bile Ducts; Bile Ducts, Intrahepatic; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Hepatic Duct, Common; Humans; Image Enhancement; Image Processing, Computer-Assisted; Injections, Intravenous; Liver; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Time Factors | 2007 |
Correlation of femoral artery flow velocity waveform with ipsilateral iliac artery stenoses assessed with magnetic resonance imaging.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Abdominal; Blood Flow Velocity; Constriction, Pathologic; Contrast Media; Diastole; Female; Femoral Artery; Gadolinium; Humans; Iliac Artery; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Peripheral Vascular Diseases; Sensitivity and Specificity; Systole; Time Factors | 2007 |
Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model.
Topics: Abdomen; Adult; Computer Simulation; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Angiography; Magnetics; Male; Meglumine; Middle Aged; Models, Biological; Organometallic Compounds; Predictive Value of Tests; Signal Processing, Computer-Assisted | 2007 |
Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update.
Topics: Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Renal Insufficiency; Risk; United States; United States Food and Drug Administration | 2008 |
Perineal angiomyxomas: can a differential diagnosis be made with imaging studies?
Topics: Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Middle Aged; Myxoma; Organometallic Compounds; Vulvar Neoplasms | 2007 |
[The Grenelle of MR contrast agents?].
Topics: Contrast Media; Europe; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Product Surveillance, Postmarketing; Renal Insufficiency; United States; United States Food and Drug Administration | 2007 |
Vascular maps on contrast-enhanced breast MR images: a new approach requiring further investigation.
Topics: Breast; Breast Neoplasms; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2008 |
Nephrogenic systemic fibrosis in Japan: advisability of keeping the administered dose as low as possible.
Topics: Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Renal Insufficiency; Risk; Risk Factors | 2008 |
Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
Topics: Aged; Choline; Citric Acid; Contrast Media; Creatine; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Meglumine; Middle Aged; Organometallic Compounds; Prostate; Prostatic Neoplasms; Whole Body Imaging | 2008 |
Anaphylactic shock after first exposure to a macrocyclic gadolinium chelate: a few comments.
Topics: Anaphylaxis; Contrast Media; Gadolinium; Humans; Meglumine; Organometallic Compounds | 2008 |
Cardiac microvascular endothelial cells express a functional Ca+ -sensing receptor.
Topics: Animals; Calcium Signaling; Endothelial Cells; Estrenes; Gadolinium; Indoles; Lanthanum; Meglumine; Myocytes, Cardiac; Neomycin; Phenylalanine; Pyrrolidinones; Rats; Rats, Wistar; Receptors, Calcium-Sensing; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium; Spermine; Tryptophan; Type C Phospholipases | 2009 |
Dynamic magnetic resonance angiography of the arteries of the hand. A comparison between an extracellular and an intravascular contrast agent.
Topics: Adult; Arteries; Contrast Media; Female; Gadolinium; Hand; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Time Factors | 2009 |
Gadolinium nephrotoxicity: case report of a rare entity and review of the literature.
Topics: Acute Kidney Injury; Aged; Arterial Occlusive Diseases; Contrast Media; Diabetic Angiopathies; Follow-Up Studies; Gadolinium; Gangrene; Humans; Leg; Magnetic Resonance Angiography; Male; Meglumine; Organometallic Compounds | 2008 |
Simple bone cyst: a radiological dilemma.
Topics: Adolescent; Biopsy; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Humans; Image Enhancement; Jaw Cysts; Magnetic Resonance Imaging; Mandibular Diseases; Meglumine; Odontogenic Cysts; Organometallic Compounds; Radiography, Panoramic | 2009 |
Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
Topics: Adult; Contrast Media; Coronary Angiography; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Angiography; Male; Meglumine; Organometallic Compounds | 2009 |
Gadoteridol-induced anaphylaxis - not a class allergy.
Topics: Aged; Anaphylaxis; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hypersensitivity; Male; Meglumine; Organometallic Compounds; Skin Tests | 2010 |
4D phase contrast MRI at 3 T: effect of standard and blood-pool contrast agents on SNR, PC-MRA, and blood flow visualization.
Topics: Algorithms; Aorta; Blood Flow Velocity; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Male; Meglumine; Organometallic Compounds; Reproducibility of Results; Rheology; Sensitivity and Specificity; Young Adult | 2010 |
Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Chronic Disease; Contrast Media; England; Female; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Selection; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors | 2010 |
Comparative studies of different gadolinium agents in brain tumors: differences between gadolinium chelates and their possible influence on imaging features.
Topics: Brain Neoplasms; Clinical Trials as Topic; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Radiography | 2010 |
Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Topics: Animals; Contrast Media; Dogs; Gadolinium; Gadolinium DTPA; Individuality; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Whole Body Imaging | 2010 |
Endomyocardial disease related to idiopathic hypereosinophilic syndrome: a cardiac magnetic resonance evaluation.
Topics: Child; Contrast Media; Diagnosis, Differential; Endomyocardial Fibrosis; Gadolinium; Humans; Hypereosinophilic Syndrome; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds | 2010 |
Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation.
Topics: Adult; Cell Proliferation; Collagen; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hyaluronic Acid; Linear Models; Magnetic Resonance Imaging; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds | 2010 |
MR imaging of atlantoaxial joint in early rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Atlanto-Axial Joint; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2010 |
Lymphatic malformation is a common component of Klippel-Trenaunay syndrome.
Topics: Adolescent; Adult; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Humans; Klippel-Trenaunay-Weber Syndrome; Lymphatic Abnormalities; Lymphatic System; Lymphedema; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Young Adult | 2010 |
High spatial resolution and high contrast visualization of brain arteries and veins: impact of blood pool contrast agent and water-selective excitation imaging at 3T.
Topics: Adult; Aged; Brain Neoplasms; Carotid-Cavernous Sinus Fistula; Cerebral Arteries; Cerebral Veins; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Intracranial Arteriovenous Malformations; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Sensitivity and Specificity; Sinus Thrombosis, Intracranial; Video Recording | 2010 |
Imaging patients with kidney disease: how do we approach contrast-related toxicity?
Topics: Acute Kidney Injury; Contrast Media; Diagnostic Imaging; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Informed Consent; Iodine Radioisotopes; Magnetic Resonance Imaging; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Selection; Radiopharmaceuticals; Renal Artery Obstruction; Risk Assessment; Risk Factors; Tomography, X-Ray Computed | 2011 |
Contrast visibility for indirect MR arthrography with different protein contents and agent relaxivities at different field strengths: an in vitro model.
Topics: Albumins; Analysis of Variance; Contrast Media; Gadolinium; Heterocyclic Compounds; Image Enhancement; In Vitro Techniques; Joint Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Phantoms, Imaging; Protein Binding; Signal Processing, Computer-Assisted | 2011 |
Incidence of immediate gadolinium contrast media reactions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anaphylaxis; Cause of Death; Child; Child, Preschool; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Gadolinium DTPA; Humans; Incidence; Infant; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Retrospective Studies; United States; Young Adult | 2011 |
Application of Benchtop-magnetic resonance imaging in a nude mouse tumor model.
Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Meglumine; Mice; Mice, Nude; Neoplasms, Germ Cell and Embryonal; Organometallic Compounds; Radionuclide Imaging; Radiopharmaceuticals; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |
Diamagnetically trapped arrays of living cells above micromagnets.
Topics: Cell Culture Techniques; Cell Growth Processes; Cell Survival; Contrast Media; Equipment Design; Gadolinium; Heterocyclic Compounds; Humans; Jurkat Cells; Magnets; Meglumine; Organometallic Compounds; Tissue Array Analysis | 2011 |
Spectral presaturation inversion recovery MR imaging sequence after gadolinium injection to differentiate fibrotic scar tissue and neoplastic strands in the mesorectal fat in patients undergoing restaging of rectal carcinoma after neoadjuvant chemo- and r
Topics: Adipose Tissue; Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Cicatrix; Contrast Media; Diagnosis, Differential; Fascia; Female; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Organometallic Compounds; Rectal Neoplasms; Retrospective Studies | 2011 |
Nebulized liposomal gadobenate dimeglumine contrast formulation for magnetic resonance imaging of larynx and trachea.
Topics: Animals; Contrast Media; Gadolinium; In Vitro Techniques; Larynx; Liposomes; Magnetic Resonance Imaging; Meglumine; Nebulizers and Vaporizers; Organometallic Compounds; Particle Size; Respiratory Mucosa; Swine; Trachea | 2011 |
T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region.
Topics: Adult; Contrast Media; Female; Fibrosis; Gadolinium; Gadolinium DTPA; Heart Diseases; Humans; Image Enhancement; Magnetic Resonance Imaging, Cine; Male; Meglumine; Myocardial Contraction; Myocardium; Organometallic Compounds; Predictive Value of Tests; Reference Values; Reproducibility of Results; Young Adult | 2012 |
Comparison of the quality of lower limb magnetic resonance angiographies performed with different paramagnetic contrast agents in relation to body mass index and ejection fraction.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Abdominal; Body Mass Index; Contrast Media; Gadolinium; Heart; Humans; Leg; Magnetic Resonance Angiography; Magnetic Resonance Imaging, Cine; Meglumine; Middle Aged; Organometallic Compounds; Peripheral Arterial Disease; Stroke Volume | 2012 |
Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice.
Topics: Adolescent; Age Factors; Benchmarking; Child; Child, Preschool; Contrast Media; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Health Care Surveys; Humans; Infant; Infant, Newborn; Kidney; Magnetic Resonance Imaging; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Practice Guidelines as Topic; Practice Patterns, Physicians'; Risk Assessment; Risk Factors; Surveys and Questionnaires | 2012 |
Comprehensive MRA of the lower limbs including high-resolution extended-phase infra-inguinal imaging with gadobenate dimeglumine: initial experience with inter-individual comparison to the blood-pool contrast agent gadofosveset trisodium.
Topics: Aged; Case-Control Studies; Contrast Media; Female; Gadolinium; Humans; Inguinal Canal; Lower Extremity; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Peripheral Arterial Disease; Pilot Projects; Radiographic Image Enhancement; Sensitivity and Specificity; Statistics, Nonparametric | 2013 |
Shoulder sonography after intraarticular fluid injection for evaluation of anterior labral tears: comparison with conventional sonography.
Topics: Adult; Arthrography; Cartilage, Articular; Contrast Media; Follow-Up Studies; Gadolinium; Humans; Injections, Intra-Articular; Male; Meglumine; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; ROC Curve; Rupture; Shoulder Injuries; Shoulder Joint; Ultrasonography; Young Adult | 2013 |
Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
Topics: Animals; Cell Line; Cell Line, Tumor; Contrast Media; Gadolinium; HeLa Cells; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Mice; Organometallic Compounds; Xenograft Model Antitumor Assays | 2012 |
Identification of a nonselective cation channel in isolated lens fiber cells that is activated by cell shrinkage.
Topics: Animals; Cell Size; Gadolinium; Gluconates; Ion Channels; Lanthanum; Lens, Crystalline; Mechanotransduction, Cellular; Meglumine; Patch-Clamp Techniques; Potassium Channels; Rats; Voltage-Dependent Anion Channels | 2012 |
Speciation of gadolinium in surface water samples and plants by hydrophilic interaction chromatography hyphenated with inductively coupled plasma mass spectrometry.
Topics: Chromatography; Contrast Media; Environmental Pollutants; Gadolinium; Gadolinium DTPA; Hydrophobic and Hydrophilic Interactions; Lepidium sativum; Meglumine; Organometallic Compounds; Plant Leaves; Reference Standards; Rivers; Spectrophotometry, Atomic; Wastewater | 2013 |
Diffusion-weighted MR imaging of focal liver lesions in the left and right lobes: is there a difference in ADC values?
Topics: Adult; Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds | 2013 |
Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: a 2-center study.
Topics: Adult; Aged; Atrial Fibrillation; Catheter Ablation; Cicatrix; Contrast Media; Female; Gadolinium; Heart Atria; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Treatment Outcome | 2013 |
Re: Comprehensive MRA of the lower limbs including high-resolution extended-phase infra-inguinal imaging with gadobenate dimeglumine: initial experience with inter-individual comparison to the blood-pool contrast agent gadofosveset trisodium. A reply.
Topics: Contrast Media; Female; Gadolinium; Humans; Lower Extremity; Magnetic Resonance Angiography; Male; Meglumine; Organometallic Compounds; Radiographic Image Enhancement | 2013 |
Re: Comprehensive MRA of the lower limbs including high-resolution extended-phase infra-inguinal imaging with gadobenate dimeglumine: initial experience with inter-individual comparison to the blood-pool contrast agent gadofosveset trisodium.
Topics: Contrast Media; Female; Gadolinium; Humans; Lower Extremity; Magnetic Resonance Angiography; Male; Meglumine; Organometallic Compounds; Radiographic Image Enhancement | 2013 |
Improved quality and diagnostic confidence achieved by use of dose-reduced gadolinium blood-pool agents for time-resolved intracranial MR angiography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Neuroimaging; Organometallic Compounds; Quality Improvement; Radiation Dosage; Reproducibility of Results; Retrospective Studies; Time Factors; Young Adult | 2014 |
Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.
Topics: Cardiomyopathy, Hypertrophic; Contrast Media; Death, Sudden, Cardiac; Delayed Diagnosis; Female; Follow-Up Studies; Gadolinium; Heart Septum; Humans; Incidence; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Organometallic Compounds; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Time Factors; United Kingdom | 2014 |
Dynamic contrast-enhanced magnetic resonance imaging can assess vascularity within fracture non-unions and predicts good outcome.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Femoral Fractures; Follow-Up Studies; Fracture Fixation; Fracture Healing; Fractures, Ununited; Gadolinium; Humans; Humeral Fractures; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Tibial Fractures; Ulna Fractures; Young Adult | 2014 |
Incidence and severity of acute adverse reactions to four different gadolinium-based MR contrast agents.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors; Severity of Illness Index | 2014 |
MR arthrography: impact of steroids, local anesthetics, and iodinated contrast material on gadolinium signal intensity in phantoms at 1.5 and 3.0 T.
Topics: Anesthetics, Local; Contrast Media; Gadolinium; Gadolinium DTPA; Injections, Intra-Articular; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Phantoms, Imaging; Signal-To-Noise Ratio; Solutions; Steroids | 2014 |
The protein and contrast agent-specific influence of pathological plasma-protein concentration levels on contrast-enhanced magnetic resonance imaging.
Topics: Blood Proteins; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Proteins | 2014 |
Analytical interference in serum iron determination reveals iron versus gadolinium transmetallation with linear gadolinium-based contrast agents.
Topics: Animals; Colorimetry; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Iron; Mass Spectrometry; Meglumine; Organometallic Compounds; Rats; Rats, Wistar | 2014 |
Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.
Topics: Contrast Media; Cooperative Behavior; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Male; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Pharmacovigilance; Registries; United States | 2014 |
Adverse allergic reactions to linear ionic gadolinium-based contrast agents: experience with 194, 400 injections.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Gadolinium DTPA; Humans; Injections; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors | 2015 |
Renal safety of intravenous gadolinium-enhanced magnetic resonance imaging in patients awaiting liver transplantation.
Topics: Contrast Media; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gadolinium; Humans; Infusions, Intravenous; Liver Cirrhosis; Liver Transplantation; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Insufficiency; Reproducibility of Results; Retrospective Studies; Watchful Waiting | 2015 |
Influence of common fixed retainers on the diagnostic quality of cranial magnetic resonance images.
Topics: Artifacts; Contrast Media; Dental Alloys; Female; Gadolinium; Gold Alloys; Humans; Image Enhancement; Magnetic Resonance Imaging; Mandible; Maxilla; Meglumine; Organometallic Compounds; Orthodontic Appliance Design; Orthodontic Retainers; Skull; Stainless Steel; Tongue | 2015 |
Residual or retained gadolinium: practical implications for radiologists and our patients.
Topics: Brain; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Globus Pallidus; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds | 2015 |
Mathematical optimization of contrast concentration for T1-weighted spoiled gradient echo imaging.
Topics: Computer Simulation; Contrast Media; Ferrosoferric Oxide; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Phantoms, Imaging; Signal Processing, Computer-Assisted | 2016 |
Toward the Prediction of Water Exchange Rates in Magnetic Resonance Imaging Contrast Agents: A Density Functional Theory Study.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Models, Chemical; Models, Molecular; Organometallic Compounds; Water | 2015 |
Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol.
Topics: Adolescent; Adult; Aged; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Kidney Failure, Chronic; Kidney Function Tests; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Product Surveillance, Postmarketing; Prospective Studies; Risk Factors | 2015 |
Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Quantitative Lung Perfusion Imaging Using the Dual-Bolus Approach: Comparison of 3 Contrast Agents and Recommendation of Feasible Doses.
Topics: Adult; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium; Gadolinium DTPA; Healthy Volunteers; Humans; Lung; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Prospective Studies | 2016 |
Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function.
Topics: Adult; Aged; Aged, 80 and over; Autopsy; Bone and Bones; Brain; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Mass Spectrometry; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Skin; Young Adult | 2016 |
Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
Topics: Adult; Aged; Aged, 80 and over; Cerebellar Nuclei; Cerebellum; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2016 |
Impact of multiparametric magnetic resonance imaging on risk group assessment of patients with prostate cancer addressed to external beam radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Contrast Media; Diffusion Magnetic Resonance Imaging; Digital Rectal Examination; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Meglumine; Middle Aged; Neoplasm Grading; Neoplasm Staging; Organometallic Compounds; Patient Care Planning; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment | 2016 |
Selenium Overload?
Topics: Contrast Media; False Positive Reactions; Female; Gadolinium; Humans; Isotopes; Meglumine; Middle Aged; Nutritional Status; Organometallic Compounds; Selenium; Spectrophotometry, Atomic | 2016 |
Acute side effects of three commonly used gadolinium contrast agents in the paediatric population.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Incidence; Infant; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies | 2016 |
Effect of Renal Function on Gadolinium-Related Signal Increases on Unenhanced T1-Weighted Brain Magnetic Resonance Imaging.
Topics: Aged; Brain; Contrast Media; Databases, Factual; Female; Gadolinium; Gadolinium DTPA; Humans; Kidney; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Dialysis; Retrospective Studies; Signal Processing, Computer-Assisted | 2016 |
Human whole blood
Topics: Blood Chemical Analysis; Computer Simulation; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Hydrogen-Ion Concentration; Magnetics; Meglumine; Monte Carlo Method; Organometallic Compounds; Oxygen; Plasma; Water | 2017 |
A liposomal Gd contrast agent does not cross the mouse placental barrier.
Topics: Animals; Contrast Media; Echo-Planar Imaging; Female; Fetus; Gadolinium; Male; Maternal-Fetal Exchange; Meglumine; Mice; Mice, Inbred BALB C; Nanoparticles; Organometallic Compounds; Placenta; Pregnancy; Uterus | 2016 |
Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Topics: Adult; Animals; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Signal Processing, Computer-Assisted | 2016 |
Gadolinium deposition disease: Initial description of a disease that has been around for a while.
Topics: Adult; Aged; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pain; Prospective Studies | 2016 |
Combined blood pool and extracellular contrast agents for pediatric and young adult cardiovascular magnetic resonance imaging.
Topics: Adolescent; Adult; Cardiovascular Diseases; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heart Defects, Congenital; Humans; Image Enhancement; Infant; Infant, Newborn; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies | 2016 |
The stability of gadolinium-based contrast agents in human serum: A reanalysis of literature data and association with clinical outcomes.
Topics: Chelating Agents; Chromatography, High Pressure Liquid; Contrast Media; Data Interpretation, Statistical; Drug Stability; Gadolinium; Gadolinium DTPA; Humans; Kinetics; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Treatment Outcome | 2017 |
Ultra-high-field (9.4 T) MRI Analysis of Contrast Agent Transport Across the Blood-Perilymph Barrier and Intrastrial Fluid-Blood Barrier in the Mouse Inner Ear.
Topics: Animals; Cochlea; Contrast Media; Ear, Inner; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Mice; Organometallic Compounds; Perilymph; Signal-To-Noise Ratio | 2017 |
Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study.
Topics: Administration, Intravenous; Adolescent; Brain; Case-Control Studies; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies | 2017 |
Lack of T1 hyperintensity in the dentate nucleus after 15 administrations of a macrocyclic contrast agent in multiple sclerosis.
Topics: Adult; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Humans; Macrocyclic Compounds; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Organometallic Compounds; Retrospective Studies; Young Adult | 2018 |
The Effect of Perinatal Gadolinium-Based Contrast Agents on Adult Mice Behavior.
Topics: Animals; Behavior, Animal; Brain; Contrast Media; Disease Models, Animal; Female; Gadolinium; Gadolinium DTPA; Humans; Male; Meglumine; Mice; Mice, Inbred BALB C; Organometallic Compounds; Pregnancy; Prenatal Exposure Delayed Effects; Spectrophotometry, Atomic | 2018 |
Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients
Topics: Adult; Brain; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2018 |
Inflammatory hepatic adenomas: Characterization with hepatobiliary MRI contrast agents.
Topics: Adenoma; Adult; Contrast Media; Diffusion Magnetic Resonance Imaging; Fatty Liver; Female; Focal Nodular Hyperplasia; Gadolinium; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Inflammation; Liver; Liver Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Young Adult | 2018 |
Non-clinical assessment of safety and gadolinium deposition after cumulative administration of gadobenate dimeglumine (MultiHance
Topics: Animals; Animals, Newborn; Brain; Cognition; Female; Femur; Gadolinium; Male; Meglumine; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2018 |
Pediatric Brain: Gadolinium Deposition in Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images Is Dependent on the Type of Contrast Agent.
Topics: Adolescent; Cerebellar Nuclei; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Globus Pallidus; Humans; Infant; Linear Models; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies | 2018 |
Frequency and Severity of Acute Allergic-Like Reactions to Intravenously Administered Gadolinium-Based Contrast Media in Children.
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Gadolinium DTPA; Humans; Male; Meglumine; Ohio; Organometallic Compounds; Retrospective Studies; Severity of Illness Index | 2018 |
Reactions to Both Nonionic Iodinated and Gadolinium-Based Contrast Media: Incidence and Clinical Characteristics.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Gadolinium DTPA; Humans; Incidence; Iodine; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors | 2018 |
Re: Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) pati
Topics: Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2018 |
Reply to: RE: effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain-a retrospective study in 158 multiple sclerosis
Topics: Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2018 |
Effects of gadolinium-based contrast agents on submandibular gland tissue in rats.
Topics: Animals; Caspase 3; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Meglumine; Organometallic Compounds; Prospective Studies; Rats; Rats, Sprague-Dawley; Submandibular Gland | 2018 |
Cerebral blood perfusion deficits using dynamic susceptibility contrast MRI with gadolinium chelates in rats with post-ischemic reperfusion without significant dynamic contrast-enhanced MRI-derived vessel permeabilities: A cautionary note.
Topics: Animals; Brain; Capillary Permeability; Carotid Artery Diseases; Cerebrovascular Circulation; Contrast Media; Female; Ferric Compounds; Gadolinium; Magnetic Resonance Imaging; Meglumine; Metal Nanoparticles; Organometallic Compounds; Rats, Sprague-Dawley; Reperfusion | 2018 |
Evaluation of Gadolinium Deposition in the Brain After MR Arthrography.
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections, Intra-Articular; Iopamidol; Joint Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2018 |
Absence of potential gadolinium toxicity symptoms following 22,897 gadoteric acid (Dotarem®) examinations, including 3,209 performed on renally insufficient individuals.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Glomerular Filtration Rate; Humans; Incidence; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Physical Examination; Retrospective Studies; Risk Factors; Young Adult | 2019 |
Negligible Risk of Acute Renal Failure Among Hospitalized Patients After Contrast-Enhanced Imaging With Iodinated Versus Gadolinium-Based Agents.
Topics: Acute Kidney Injury; Contrast Media; Female; Gadolinium; Humans; Inpatients; Iodine; Iohexol; Israel; Kidney; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2019 |
Gadolinium-induced anaphylaxis with positive skin test results.
Topics: Adult; Allergens; Anaphylaxis; Angioedema; Contrast Media; Diphenhydramine; Drug Hypersensitivity; Face; Female; Gadolinium; Histamine H1 Antagonists; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Skin Tests; Syncope; Urticaria | 2019 |
Magnetic resonance angiography imaging of pulmonary embolism using agents with blood pool properties as an alternative to computed tomography to avoid radiation exposure.
Topics: Adult; Computed Tomography Angiography; Contrast Media; Feasibility Studies; Female; Gadolinium; Humans; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Pelvis; Phlebography; Prospective Studies; Pulmonary Embolism; Radiation Exposure; Sensitivity and Specificity; Thorax; Venous Thrombosis | 2019 |
Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents.
Topics: Adult; Brain; Cerebellar Nuclei; Contrast Media; Environmental Exposure; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds | 2019 |
Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model.
Topics: Animals; Brain; Diabetes Mellitus, Experimental; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Rats; Rats, Wistar; Time Factors | 2019 |
Gadolinium Deposition in the Brain in a Large Animal Model: Comparison of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Topics: Animals; Brain; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Meglumine; Models, Animal; Organometallic Compounds; Sheep | 2019 |
Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.
Topics: Aged; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prostate; Prostatic Diseases; Reproducibility of Results; Retrospective Studies | 2019 |
Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
Topics: Acute Disease; Adult; Aged; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors | 2019 |
Extent and spatial distribution of left atrial arrhythmogenic sites, late gadolinium enhancement at magnetic resonance imaging, and low-voltage areas in patients with persistent atrial fibrillation: comparison of imaging vs. electrical parameters of fibro
Topics: Atrial Fibrillation; Atrial Function, Left; Catheter Ablation; Contrast Media; Electrophysiologic Techniques, Cardiac; Female; Fibrosis; Gadolinium; Heart Atria; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Reproducibility of Results | 2019 |
Late Gadolinium Enhancement Magnetic Resonance Imaging Guided Treatment of Post-Atrial Fibrillation Ablation Recurrent Arrhythmia.
Topics: Aged; Atrial Fibrillation; Atrial Remodeling; Catheter Ablation; Contrast Media; Female; Follow-Up Studies; Gadolinium; Heart Atria; Heart Conduction System; Heart Rate; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging, Cine; Male; Meglumine; Organometallic Compounds; Postoperative Period; Recurrence; Retrospective Studies; Surgery, Computer-Assisted; Time Factors | 2019 |
Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging.
Topics: Animals; Contrast Media; Erythrocytes; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; In Vitro Techniques; Leukocytes; Magnetic Resonance Imaging; Male; Meglumine; Mice; Models, Animal; Organometallic Compounds; Spectrophotometry, Atomic | 2020 |
Dynamic, Simultaneous Concentration Mapping of Multiple MRI Contrast Agents with Dual Contrast - Magnetic Resonance Fingerprinting.
Topics: Animals; Cell Line, Tumor; Contrast Media; Female; Gadolinium; Glioma; Humans; Magnetic Resonance Imaging; Meglumine; Mice; Mice, Nude; Neoplasms, Experimental; Organometallic Compounds | 2019 |
Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.
Topics: Animals; Brain; Chromatography, Gel; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Injections, Intravenous; Meglumine; Models, Animal; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 2020 |
Response to LTE "Re: Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study".
Topics: Brain; Case-Control Studies; Child; Gadolinium; Humans; Meglumine; Organometallic Compounds | 2020 |
Re: Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study.
Topics: Brain; Case-Control Studies; Child; Contrast Media; Gadolinium; Humans; Meglumine; Organometallic Compounds | 2020 |
Signal Enhancement and Enhancement Kinetics of Gadobutrol, Gadoteridol, and Gadoterate Meglumine in Various Body Regions: A Comparative Animal Study.
Topics: Animals; Brain; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Injections, Intravenous; Liver; Magnetic Resonance Imaging; Male; Meglumine; Models, Animal; Organometallic Compounds; Prostate; Rabbits | 2020 |
The anterior eye chamber: entry of the natural excretion pathway of gadolinium contrast agents?
Topics: Anterior Chamber; Child, Preschool; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Infant; Infant, Newborn; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retinal Neoplasms; Retinoblastoma; Retrospective Studies | 2020 |
Natural polymeric nanoparticles as a non-invasive probe for mesenchymal stem cell labelling.
Topics: Alginates; Animals; Cell Tracking; Chitosan; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Meglumine; Mesenchymal Stem Cells; Mice; Nanoparticles; Organometallic Compounds; Particle Size | 2020 |
Nebulised Gadolinium-Based Nanoparticles for a Multimodal Approach: Quantitative and Qualitative Lung Distribution Using Magnetic Resonance and Scintigraphy Imaging in Isolated Ventilated Porcine Lungs.
Topics: Aerosols; Animals; Contrast Media; Gadolinium; Humans; Lung; Magnetic Resonance Imaging; Meglumine; Metal Nanoparticles; Nebulizers and Vaporizers; Organ Culture Techniques; Organometallic Compounds; Precision Medicine; Radionuclide Imaging; Respiration, Artificial; Swine | 2020 |
Interaction of macrocyclic gadolinium-based MR contrast agents with Type I collagen. Equilibrium and kinetic studies.
Topics: Animals; Cattle; Collagen Type I; Contrast Media; Coordination Complexes; Gadolinium; Heterocyclic Compounds; Kinetics; Ligands; Macrocyclic Compounds; Magnetic Resonance Imaging; Meglumine; Models, Molecular; Organometallic Compounds; Rats; Structure-Activity Relationship; Thermodynamics | 2020 |
MRI demonstration of gadolinium deposition in bone after monthly triple-dose gadopentetate dimeglumine and correlation with frequency of hypophosphatemia.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Hypophosphatemia; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies | 2021 |
Use of Gadolinium in Individuals with Reduced Kidney Function.
Topics: Aged; Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Male; Meglumine; Nephrectomy; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Pancreatic Neoplasms; Renal Dialysis; Risk Assessment | 2021 |
High-resolution T
Topics: Animals; Biocompatible Materials; Contrast Media; Dextrans; Ferric Compounds; Gadolinium; Magnetic Resonance Imaging; Meglumine; Mice; Mice, Inbred BALB C; Microvessels; Nanoparticles; Organometallic Compounds; Particle Size; Polysaccharides; Rabbits; Rats; Rats, Sprague-Dawley | 2021 |
Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study.
Topics: Adult; Aged; Comorbidity; Contrast Media; Cross-Sectional Studies; Dextrans; Europe; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Young Adult | 2021 |
Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats.
Topics: Administration, Intravenous; Animals; Brain; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Kinetics; Male; Meglumine; Models, Animal; Organometallic Compounds; Prospective Studies; Rats; Rats, Sprague-Dawley | 2021 |
Editorial for "Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine and Gadobutrol to rats".
Topics: Administration, Intravenous; Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rats | 2021 |
Comparison of Human Tissue Gadolinium Retention and Elimination between Gadoteridol and Gadobenate.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Brain; Cadaver; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Male; Meglumine; Middle Aged; Organometallic Compounds; Skin; Spectrophotometry, Atomic | 2021 |
Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging.
Topics: Aging; Brain; Breast Neoplasms; Case-Control Studies; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Globus Pallidus; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Retrospective Studies | 2022 |
Small Brain Lesion Enhancement and Gadolinium Deposition in the Rat Brain: Comparison Between Gadopiclenol and Gadobenate Dimeglumine.
Topics: Animals; Azabicyclo Compounds; Brain; Contrast Media; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rats | 2022 |
An NMR relaxometry approach for quantitative investigation of the transchelation of gadolinium ions from GBCAs to a competing macromolecular chelator.
Topics: Chelating Agents; Gadolinium; Gadolinium DTPA; Heparin; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Zinc | 2021 |
Comprehensive Speciation Analysis of Residual Gadolinium in Deep Cerebellar Nuclei in Rats Repeatedly Administered With Gadoterate Meglumine or Gadodiamide.
Topics: Animals; Brain; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Meglumine; Organometallic Compounds; Phosphates; Rats; Rats, Sprague-Dawley; Water | 2022 |
The Effect of Magnetic Field Gradient and Gadolinium-Based MRI Contrast Agent Dotarem on Mouse Macrophages.
Topics: Animals; Contrast Media; Gadolinium; Macrophages; Magnetic Fields; Magnetic Resonance Imaging; Meglumine; Mice; Organometallic Compounds | 2022 |
Gadolinium-based contrast agents for imaging of the central nervous system: A multicenter European prospective study.
Topics: Adult; Central Nervous System; Child; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Prospective Studies | 2022 |
Safety profile of Gadoterate meglumine on the renal function of patients with severe kidney disease.
Topics: Contrast Media; Gadolinium; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies | 2022 |
Gadolinium Deposition in the Rat Brain Measured with Quantitative MRI versus Elemental Mass Spectrometry.
Topics: Animals; Brain; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Mass Spectrometry; Meglumine; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 2023 |
Stability testing of gadoteridol and gadobenate dimeglumine formulations under exposure to high-intensity focused ultrasound.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Ligands; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2022 |
Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study.
Topics: Bile; Cholangiography; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Meglumine | 2023 |
Breast DWI Analyzed Before and After Gadolinium Contrast Administration-An Intrapatient Analysis on 1.5 T and 3.0 T.
Topics: Breast Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Gadolinium; Gadolinium DTPA; Humans; Meglumine | 2023 |